<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Hodgkin's lymphoma - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Hodgkin%27s_lymphoma" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Hodgkin%27s_lymphoma" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Hodgkin%27s_lymphoma" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Hodgkin's_lymphoma","wgTitle":"Hodgkin's lymphoma","wgCurRevisionId":669324052,"wgRevisionId":669324052,"wgArticleId":23713759,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Pages with DOIs inactive since 2015","Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from October 2008","Articles needing additional references from January 2009","All articles needing additional references","Articles with unsourced statements from August 2014","Articles with unsourced statements from September 2013","Commons category with local link same as on Wikidata","Articles that use a Medicine navs subtemplate","Rare cancers","Hodgkin's lymphoma","Infectious causes of cancer"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Hodgkin's_lymphoma","wgRelevantArticleId":23713759,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Hodgkin_lymphoma","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/f/f3/Hodgkin_lymphoma_cytology_large.jpg/100px-Hodgkin_lymphoma_cytology_large.jpg","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Hodgkin%27s_lymphoma","wgWikibaseItemId":"Q209369"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Hodgkin_s_lymphoma skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Hodgkin's lymphoma</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Hodgkin_lymphoma&amp;redirect=no" title="Hodgkin lymphoma">Hodgkin lymphoma</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Hodgkin Lymphoma</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Hodgkin_lymphoma_cytology_large.jpg" class="image"><img alt="Hodgkin lymphoma cytology large.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f3/Hodgkin_lymphoma_cytology_large.jpg/230px-Hodgkin_lymphoma_cytology_large.jpg" width="230" height="169" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f3/Hodgkin_lymphoma_cytology_large.jpg/345px-Hodgkin_lymphoma_cytology_large.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f3/Hodgkin_lymphoma_cytology_large.jpg/460px-Hodgkin_lymphoma_cytology_large.jpg 2x" data-file-width="3300" data-file-height="2428" /></a>
<div><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> showing Hodgkin lymphoma (<a href="/wiki/Field_stain" title="Field stain">Field stain</a>)</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Hematology" title="Hematology">Hematology</a> and <a href="/wiki/Oncology" title="Oncology">oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C81">C81</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=201">201</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td>9650/3-9667/3</td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb5973.htm">5973</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000580.htm">000580</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic1022.htm">med/1022</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">NCI</a></th>
<td><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/hodgkin">Hodgkin's lymphoma</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/hodgkins-lymphoma-pro">Hodgkin's lymphoma</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D006689">D006689</a></td>
</tr>
</table>
<p><b>Hodgkin lymphoma</b>,<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup> also known as <b>Hodgkin's lymphoma</b> or <b>Hodgkin's disease</b>,<sup id="cite_ref-Lozano_2012_2-0" class="reference"><a href="#cite_note-Lozano_2012-2"><span>[</span>2<span>]</span></a></sup> is a type of <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a>, in which <a href="/wiki/Cancer" title="Cancer">cancer</a> originates from <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a> called <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a>.</p>
<p>A history of <a href="/wiki/Infectious_mononucleosis" title="Infectious mononucleosis">infectious mononucleosis</a> due to infection by <a href="/wiki/Epstein%E2%80%93Barr_virus" title="Epstein–Barr virus">Epstein–Barr virus</a> (EBV) may increase risk of HL, but the precise contribution of Epstein–Barr virus remains largely unknown.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> Hodgkin lymphoma is characterized by the orderly spread of disease from one <a href="/wiki/Lymph_node" title="Lymph node">lymph node</a> group to another and by the development of <a href="/wiki/B_symptoms" title="B symptoms">systemic symptoms</a> with advanced disease. When Hodgkins cells are examined microscopically, multinucleated <a href="/wiki/Reed%E2%80%93Sternberg_cell" title="Reed–Sternberg cell">Reed–Sternberg cells</a> (RS cells) are the characteristic <a href="/wiki/Histopathology" title="Histopathology">histopathologic</a> finding.</p>
<p>Hodgkin lymphoma may be treated with <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, or <a href="/wiki/Hematopoietic_stem_cell_transplantation" title="Hematopoietic stem cell transplantation">hematopoietic stem cell transplantation</a>, with the choice of treatment depending on the age and sex of the patient and the stage, bulk, and histological subtype of the disease. The overall <a href="/wiki/Five-year_survival_rate" title="Five-year survival rate">five-year survival rate</a> in the United States for 2004–2010 is 85%.<sup id="cite_ref-seer_5-0" class="reference"><a href="#cite_note-seer-5"><span>[</span>5<span>]</span></a></sup> There have been many cases of individuals living &gt;40 years after diagnosis. However, few studies follow people as long as 25 years, and those studies are of older treatments with more life-threatening adverse effects. There is insufficient data available about the long-term outcomes of newer, less-toxic regimens and ones which limit radiation exposure. Radiation treatments, and some chemotherapy drugs, pose a risk of causing potentially fatal secondary cancers, heart disease, and lung disease 40 or more years later. Modern treatments greatly minimise the chances of these late effects.<sup id="cite_ref-Armitage2010_6-0" class="reference"><a href="#cite_note-Armitage2010-6"><span>[</span>6<span>]</span></a></sup></p>
<p>The disease occurrence shows two peaks: the first in young adulthood (age 15–35) and the second in those over 55 years old.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> It was named after <a href="/wiki/Thomas_Hodgkin" title="Thomas Hodgkin">Thomas Hodgkin</a>, who first described abnormalities in the <a href="/wiki/Lymph_system" title="Lymph system" class="mw-redirect">lymph system</a> in 1832.<sup id="cite_ref-Hoppe2007_8-0" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-Hodgkin1832_9-0" class="reference"><a href="#cite_note-Hodgkin1832-9"><span>[</span>9<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Types"><span class="tocnumber">1.1</span> <span class="toctext">Types</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Staging"><span class="tocnumber">1.2</span> <span class="toctext">Staging</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Pathology"><span class="tocnumber">3.1</span> <span class="toctext">Pathology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Management"><span class="tocnumber">4</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Adverse_effects"><span class="tocnumber">4.1</span> <span class="toctext">Adverse effects</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-9"><a href="#Prognosis"><span class="tocnumber">5</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#UK"><span class="tocnumber">6.1</span> <span class="toctext">UK</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#History"><span class="tocnumber">7</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Notable_cases"><span class="tocnumber">8</span> <span class="toctext">Notable cases</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#See_also"><span class="tocnumber">9</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Further_reading"><span class="tocnumber">11</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Types">Types</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=2" title="Edit section: Types">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Classical Hodgkin lymphoma (excluding <a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">nodular lymphocyte predominant Hodgkin's lymphoma</a>) can be subclassified into 4 <a href="/wiki/Anatomical_pathology" title="Anatomical pathology">pathologic</a> subtypes based upon Reed–Sternberg cell <a href="/wiki/Morphology_(biology)" title="Morphology (biology)">morphology</a> and the composition of the reactive cell <a href="/wiki/Infiltration_(medical)" title="Infiltration (medical)">infiltrate</a> seen in the <a href="/wiki/Lymph_node" title="Lymph node">lymph node</a> <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> specimen (the cell composition around the Reed–Sternberg cell(s)).</p>
<table class="wikitable">
<tr>
<th>Name</th>
<th>Description</th>
<th><a href="/wiki/ICD-10" title="ICD-10">ICD-10</a></th>
<th><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">ICD-O</a></th>
</tr>
<tr>
<td><a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">Nodular sclerosing HL</a></td>
<td>Is the most common subtype and is composed of large <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">tumor</a> <i><b>nodules</b></i> showing scattered lacunar classical RS cells set in a background of reactive <a href="/wiki/Lymphocytes" title="Lymphocytes" class="mw-redirect">lymphocytes</a>, <a href="/wiki/Eosinophils" title="Eosinophils" class="mw-redirect">eosinophils</a> and <a href="/wiki/Plasma_cells" title="Plasma cells" class="mw-redirect">plasma cells</a> with varying degrees of collagen fibrosis/<i><b>sclerosis</b></i>.</td>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C81.1">C81.1</a></td>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I96633/">9663/3</a></td>
</tr>
<tr>
<td>Mixed-cellularity subtype</td>
<td>Is a common subtype and is composed of numerous classic RS cells admixed with numerous inflammatory cells including lymphocytes, histiocytes, eosinophils, and plasma cells without sclerosis. This type is most often associated with EBV infection and may be confused with the early, so-called 'cellular' phase of nodular sclerosing CHL.</td>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C81.2">C81.2</a></td>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I96523/">9652/3</a>.</td>
</tr>
<tr>
<td><a href="/wiki/Lymphocyte" title="Lymphocyte">Lymphocyte</a>-rich or Lymphocytic predominance</td>
<td>Is a rare subtype, show many features which may cause diagnostic confusion with nodular lymphocyte predominant B-cell <a href="/wiki/Non-Hodgkin%27s_Lymphoma" title="Non-Hodgkin's Lymphoma" class="mw-redirect">Non-Hodgkin's Lymphoma</a> (B-NHL). This form also has the most favorable prognosis.</td>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C81.0">C81.0</a></td>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I96513/">9651/3</a></td>
</tr>
<tr>
<td>Lymphocyte depleted</td>
<td>Is a rare subtype, composed of large numbers of often pleomorphic RS cells with only few reactive lymphocytes which may easily be confused with <a href="/wiki/Diffuse_large_cell_lymphoma" title="Diffuse large cell lymphoma" class="mw-redirect">diffuse large cell lymphoma</a>. Many cases previously classified within this category would now be reclassified under <a href="/wiki/Anaplastic_large_cell_lymphoma" title="Anaplastic large cell lymphoma" class="mw-redirect">anaplastic large cell lymphoma</a>.<sup id="cite_ref-urlHMDS:_Hodgkins_Lymphoma_10-0" class="reference"><a href="#cite_note-urlHMDS:_Hodgkins_Lymphoma-10"><span>[</span>10<span>]</span></a></sup></td>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C81.3">C81.3</a></td>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I96533/">9653/3</a></td>
</tr>
<tr>
<td>Unspecified</td>
<td></td>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C81.9">C81.9</a></td>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I96503/">9650/3</a></td>
</tr>
</table>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Hodgkin_lymphoma_%281%29_mixed_cellulary_type.jpg/220px-Hodgkin_lymphoma_%281%29_mixed_cellulary_type.jpg" width="220" height="166" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Hodgkin_lymphoma_%281%29_mixed_cellulary_type.jpg/330px-Hodgkin_lymphoma_%281%29_mixed_cellulary_type.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Hodgkin_lymphoma_%281%29_mixed_cellulary_type.jpg/440px-Hodgkin_lymphoma_%281%29_mixed_cellulary_type.jpg 2x" data-file-width="700" data-file-height="527" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpg" class="internal" title="Enlarge"></a></div>
Lymph node <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> showing Hodgkin's lymphoma, mixed-cellularity type</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Hodgkin_Lymphoma_CT2.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ee/Hodgkin_Lymphoma_CT2.jpg/220px-Hodgkin_Lymphoma_CT2.jpg" width="220" height="113" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ee/Hodgkin_Lymphoma_CT2.jpg/330px-Hodgkin_Lymphoma_CT2.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ee/Hodgkin_Lymphoma_CT2.jpg/440px-Hodgkin_Lymphoma_CT2.jpg 2x" data-file-width="1079" data-file-height="552" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Hodgkin_Lymphoma_CT2.jpg" class="internal" title="Enlarge"></a></div>
CT image of a 46-year-old patient with Hodgkin's lymphoma, image at neck height. On the left side of the patient's neck enlarged lymph nodes are visible (marked in red).</div>
</div>
</div>
<p><a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">Nodular lymphocyte predominant Hodgkin's lymphoma</a> expresses <a href="/wiki/CD20" title="CD20">CD20</a>, and is not currently considered a form of classical Hodgkin's.</p>
<p>For the other forms, although the traditional <a href="/wiki/B_cell" title="B cell">B cell</a> markers (such as <a href="/wiki/CD20" title="CD20">CD20</a>) are not expressed on all cells,<sup id="cite_ref-urlHMDS:_Hodgkins_Lymphoma_10-1" class="reference"><a href="#cite_note-urlHMDS:_Hodgkins_Lymphoma-10"><span>[</span>10<span>]</span></a></sup> Reed–Sternberg cells are usually of B cell origin.<sup id="cite_ref-pmid12078890_11-0" class="reference"><a href="#cite_note-pmid12078890-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-pmid16385563_12-0" class="reference"><a href="#cite_note-pmid16385563-12"><span>[</span>12<span>]</span></a></sup> Although Hodgkin's is now frequently grouped with other <a href="/wiki/B_cell" title="B cell">B cell</a> malignancies, some <a href="/wiki/T_cell" title="T cell">T cell</a> markers (such as <a href="/wiki/CD2" title="CD2">CD2</a> and <a href="/wiki/CD4" title="CD4">CD4</a>) are occasionally expressed.<sup id="cite_ref-pmid16056244_13-0" class="reference"><a href="#cite_note-pmid16056244-13"><span>[</span>13<span>]</span></a></sup> However, this may be an artifact of the ambiguity inherent in the diagnosis.</p>
<p>Hodgkin cells produce <a href="/wiki/Interleukin-21" title="Interleukin-21" class="mw-redirect">interleukin-21</a> (IL-21), which was once thought to be exclusive to <a href="/wiki/T_cell" title="T cell">T cells</a>. This feature may explain the behavior of classical Hodgkin's lymphoma, including clusters of other immune cells gathered around HL cells (infiltrate) in cultures.<sup id="cite_ref-blood-112-8_14-0" class="reference"><a href="#cite_note-blood-112-8-14"><span>[</span>14<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Staging">Staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=3" title="Edit section: Staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The staging is the same for both Hodgkin's as well as non-Hodgkin's lymphomas.</p>
<p>After Hodgkin lymphoma is diagnosed, a patient will be <i><a href="/wiki/Cancer_staging" title="Cancer staging">staged</a></i>: that is, they will undergo a series of tests and procedures that will determine what areas of the body are affected. These procedures may include documentation of their <a href="/wiki/Histology" title="Histology">histology</a>, a physical examination, blood tests, chest <a href="/wiki/X-ray" title="X-ray">X-ray</a> radiographs, <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">computed tomography</a> (CT)/<a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">Positron emission tomography</a> (PET)/<a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI) scans of the chest, abdomen and pelvis, and usually a bone marrow biopsy. <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">Positron emission tomography</a> (PET) scan is now used instead of the <a href="/wiki/Gallium_scan" title="Gallium scan" class="mw-redirect">gallium scan</a> for staging. On the PET scan, sites involved with lymphoma light up very brightly enabling accurate and reproducible imaging.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> In the past, a <a href="/wiki/Lymphangiogram" title="Lymphangiogram" class="mw-redirect">lymphangiogram</a> or surgical <a href="/wiki/Laparotomy" title="Laparotomy">laparotomy</a> (which involves opening the abdominal cavity and visually inspecting for tumors) were performed. Lymphangiograms or laparotomies are very rarely performed, having been supplanted by improvements in imaging with the CT scan and PET scan.</p>
<p>On the basis of this staging, the patient will be classified according to a staging classification (the <a href="/wiki/Ann_Arbor_staging_classification" title="Ann Arbor staging classification" class="mw-redirect">Ann Arbor staging classification</a> scheme is a common one):</p>
<ul>
<li>Stage I is involvement of a single lymph node region (I) (mostly the cervical region) or single extralymphatic site (Ie);</li>
<li>Stage II is involvement of two or more lymph node regions on the same side of the <a href="/wiki/Diaphragm_(anatomy)" title="Diaphragm (anatomy)" class="mw-redirect">diaphragm</a> (II) or of one lymph node region and a contiguous extralymphatic site (IIe);</li>
<li>Stage III is involvement of lymph node regions on both sides of the diaphragm, which may include the <a href="/wiki/Spleen" title="Spleen">spleen</a> (IIIs) and/or limited contiguous extralymphatic organ or site (IIIe, IIIes);</li>
<li>Stage IV is disseminated involvement of one or more extralymphatic organs.</li>
</ul>
<p>The absence of systemic symptoms is signified by adding 'A' to the stage; the presence of systemic symptoms is signified by adding 'B' to the stage. For localised extranodal extension from mass of nodes that does not advance the stage, subscript 'E' is added. Splenic involvement is signified by adding 'S' to the stage. The inclusion of "bulky disease" is signified by 'X'.</p>
<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:15px auto;"><a href="/wiki/File:Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg/103px-Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg.png" width="103" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg/154px-Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/85/Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg/206px-Diagram_showing_stage_1_Hogkin%27s_lymphoma_CRUK_191.svg.png 2x" data-file-width="342" data-file-height="399" /></a></div>
</div>
<div class="gallerytext">
<p>Stage 1 Hodgkin's lymphoma</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:15px auto;"><a href="/wiki/File:Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg/103px-Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg.png" width="103" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg/154px-Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg/206px-Diagram_showing_stage_2_Hodgkin%27s_lymphoma_CRUK_208.svg.png 2x" data-file-width="342" data-file-height="399" /></a></div>
</div>
<div class="gallerytext">
<p>Stage 2 Hodgkin's lymphoma</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:15px auto;"><a href="/wiki/File:Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/11/Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg/103px-Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg.png" width="103" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/11/Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg/154px-Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/11/Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg/206px-Diagram_showing_stage_3_Hodgkin%27s_lymphoma_CRUK_221.svg.png 2x" data-file-width="342" data-file-height="399" /></a></div>
</div>
<div class="gallerytext">
<p>Stage 3 Hodgkin's lymphoma</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:15px auto;"><a href="/wiki/File:Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/8f/Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg/102px-Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg.png" width="102" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/8f/Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg/154px-Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/8f/Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg/205px-Diagram_showing_stage_4_Hodgkin%27s_lymphoma_CRUK_230.svg.png 2x" data-file-width="341" data-file-height="399" /></a></div>
</div>
<div class="gallerytext">
<p>Stage 4 Hodgkin's lymphoma</p>
</div>
</div>
</li>
</ul>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=4" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Patients with Hodgkin's lymphoma may present with the following symptoms:</p>
<ul>
<li><a href="/wiki/Lymph_nodes" title="Lymph nodes" class="mw-redirect">Lymph nodes</a>: the most common symptom of Hodgkin's is the painless enlargement of one or more lymph nodes, or <a href="/wiki/Lymphadenopathy" title="Lymphadenopathy">lymphadenopathy</a>. The nodes may also feel rubbery and swollen when examined. The nodes of the neck and shoulders (<a href="/wiki/Cervical_lymph_nodes" title="Cervical lymph nodes">cervical</a> and <a href="/wiki/Supraclavicular_lymph_nodes" title="Supraclavicular lymph nodes">supraclavicular</a>) are most frequently involved (80–90% of the time, on average). The lymph nodes of the chest are often affected, and these may be noticed on a <a href="/wiki/Chest_radiograph" title="Chest radiograph">chest radiograph</a>.</li>
<li><a href="/wiki/Pruritus" title="Pruritus" class="mw-redirect">Itchy skin</a></li>
<li><a href="/wiki/Sleep_hyperhidrosis" title="Sleep hyperhidrosis" class="mw-redirect">Night sweats</a></li>
<li>Unexplained <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a></li>
<li><a href="/wiki/Splenomegaly" title="Splenomegaly">Splenomegaly</a>: enlargement of the <a href="/wiki/Spleen" title="Spleen">spleen</a> occurs in about 30% of people with Hodgkin's lymphoma. The enlargement, however, is seldom massive and the size of the spleen may fluctuate during the course of treatment.</li>
<li><a href="/wiki/Hepatomegaly" title="Hepatomegaly">Hepatomegaly</a>: enlargement of the <a href="/wiki/Liver" title="Liver">liver</a>, due to liver involvement, is present in about 5% of cases.</li>
<li><a href="/wiki/Hepatosplenomegaly" title="Hepatosplenomegaly">Hepatosplenomegaly</a>: the enlargement of both the liver and spleen caused by the same disease.</li>
<li>Pain following alcohol consumption: classically, involved nodes are painful after alcohol consumption, though this phenomenon is very uncommon,<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> occurring in only two to three percent of people with Hodgkin's lymphoma,<sup id="cite_ref-Kearsley1998_17-0" class="reference"><a href="#cite_note-Kearsley1998-17"><span>[</span>17<span>]</span></a></sup> thus having a low <a href="/wiki/Sensitivity_and_specificity" title="Sensitivity and specificity">sensitivity</a>. On the other hand, its <a href="/wiki/Sensitivity_and_specificity" title="Sensitivity and specificity">specificity</a> is high enough for it to be regarded as a <a href="/wiki/Pathognomonic" title="Pathognomonic">pathognomonic</a> sign of Hodgkin lymphoma.<sup id="cite_ref-Kearsley1998_17-1" class="reference"><a href="#cite_note-Kearsley1998-17"><span>[</span>17<span>]</span></a></sup> The pain typically has an onset within minutes after ingesting alcohol, and is usually felt as coming from the vicinity where there is an involved lymph node.<sup id="cite_ref-Kearsley1998_17-2" class="reference"><a href="#cite_note-Kearsley1998-17"><span>[</span>17<span>]</span></a></sup> The pain has been described as either sharp and stabbing or dull and aching.<sup id="cite_ref-Kearsley1998_17-3" class="reference"><a href="#cite_note-Kearsley1998-17"><span>[</span>17<span>]</span></a></sup></li>
<li><a href="/wiki/Back_pain" title="Back pain">Back pain</a>: nonspecific back pain (pain that cannot be localised or its cause determined by examination or scanning techniques) has been reported in some cases of Hodgkin's lymphoma. The lower back is most often affected.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2008)">citation needed</span></a></i>]</sup></li>
<li>Red-coloured patches on the skin, easy bleeding and <a href="/wiki/Petechiae" title="Petechiae" class="mw-redirect">petechiae</a> due to low platelet count (as a result of bone marrow infiltration, increased trapping in the spleen etc.—i.e. decreased production, increased removal)</li>
<li>Systemic symptoms: about one-third of patients with Hodgkin's disease may also present with systemic symptoms, including low-grade <a href="/wiki/Fever" title="Fever">fever</a>; <a href="/wiki/Night_sweats" title="Night sweats">night sweats</a>; unexplained weight loss of at least 10% of the patient's total body mass in six months or less, itchy skin (<a href="/wiki/Itch" title="Itch">pruritus</a>) due to increased levels of <a href="/wiki/Eosinophils" title="Eosinophils" class="mw-redirect">eosinophils</a> in the bloodstream; or <a href="/wiki/Fatigue_(physical)" title="Fatigue (physical)" class="mw-redirect">fatigue</a> (lassitude). Systemic symptoms such as fever, night sweats, and weight loss are known as <a href="/wiki/B_symptoms" title="B symptoms">B symptoms</a>; thus, presence of fever, weight loss, and night sweats indicate that the patient's stage is, for example, 2B instead of 2A.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup></li>
<li>Cyclical fever: patients may also present with a cyclical high-grade fever known as the <a href="/wiki/Pel-Ebstein_fever" title="Pel-Ebstein fever">Pel-Ebstein fever</a>,<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup> or more simply "P-E fever". However, there is debate as to whether the P-E fever truly exists.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></li>
<li><a href="/wiki/Nephrotic_syndrome" title="Nephrotic syndrome">Nephrotic syndrome</a> can occur in individuals with Hodgkin's lymphoma and is most commonly caused by <a href="/wiki/Minimal_change_disease" title="Minimal change disease">minimal change disease</a>.<sup id="cite_ref-pmid20200355_21-0" class="reference"><a href="#cite_note-pmid20200355-21"><span>[</span>21<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=5" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox ambox-content ambox-Unreferenced" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="262" data-file-height="204" /></a></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This section <b>does not <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">cite</a> any <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">references or sources</a></b>. <span class="hide-when-compact">Please help improve this section by <a href="/wiki/Help:Introduction_to_referencing/1" title="Help:Introduction to referencing/1">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href="/wiki/Wikipedia:Verifiability#Burden_of_evidence" title="Wikipedia:Verifiability">removed</a>.</span> <small><i>(January 2009)</i></small></span></td>
</tr>
</table>
<p>Hodgkin's lymphoma must be distinguished from non-cancerous causes of lymph node swelling (such as various infections) and from other types of cancer. Definitive diagnosis is by lymph node <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> (usually excisional biopsy with microscopic examination). <a href="/wiki/Blood_test" title="Blood test">Blood tests</a> are also performed to assess function of major organs and to assess safety for <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>. <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">Positron emission tomography</a> (PET) is used to detect small deposits that do not show on CT scanning. PET scans are also useful in functional imaging (by using a radiolabeled glucose to image tissues of high metabolism). In some cases a <a href="/wiki/Gallium_imaging" title="Gallium imaging" class="mw-redirect">Gallium Scan</a> may be used instead of a PET scan.</p>
<h3><span class="mw-headline" id="Pathology">Pathology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=6" title="Edit section: Pathology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<dl>
<dt>Macroscopy</dt>
</dl>
<p>Affected lymph nodes (most often, laterocervical lymph nodes) are enlarged, but their shape is preserved because the capsule is not invaded. Usually, the cut surface is white-grey and uniform; in some histological subtypes (e.g. <a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">nodular sclerosis</a>) a nodular aspect may appear.</p>
<p>A <a href="/wiki/Fibrin_ring_granuloma" title="Fibrin ring granuloma">fibrin ring granuloma</a> may be seen.</p>
<dl>
<dt>Microscopy</dt>
</dl>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/02/Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg/220px-Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg" width="220" height="141" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/02/Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg/330px-Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/02/Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg/440px-Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg 2x" data-file-width="1800" data-file-height="1152" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Reed-Sternberg_lymphocyte_nci-vol-7172-300.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of a classic Reed–Sternberg cell</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/39/Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg/220px-Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg" width="220" height="160" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/39/Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg/330px-Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/39/Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg/440px-Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg 2x" data-file-width="1595" data-file-height="1160" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Popcorn_cell_in_nodular_lymphocyte_predominant_Hodgkin_lymphoma_-_very_high_mag_cropped.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> showing a "popcorn cell", the Reed–Sternberg cell variant seen in <a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin_lymphoma" title="Nodular lymphocyte predominant Hodgkin lymphoma" class="mw-redirect">nodular lymphocyte predominant Hodgkin lymphoma</a>. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a></div>
</div>
</div>
<p>Microscopic examination of the lymph node biopsy reveals complete or partial effacement of the lymph node architecture by scattered large malignant cells known as <a href="/wiki/Reed%E2%80%93Sternberg_cell" title="Reed–Sternberg cell">Reed-Sternberg cells</a> (RSC) (typical and variants) admixed within a reactive cell infiltrate composed of variable proportions of lymphocytes, histiocytes, eosinophils, and plasma cells. The Reed–Sternberg cells are identified as large often bi-nucleated cells with prominent nucleoli and an unusual <a href="/wiki/CD45" title="CD45" class="mw-redirect">CD45</a>-, <a href="/wiki/CD30" title="CD30">CD30</a>+, <a href="/wiki/CD15" title="CD15">CD15</a>+/- immunophenotype. In approximately 50% of cases, the Reed–Sternberg cells are infected by the Epstein–Barr virus.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2014)">citation needed</span></a></i>]</sup></p>
<p>Characteristics of classic Reed–Sternberg cells include large size (20–50 micrometres), abundant, amphophilic, finely granular/homogeneous cytoplasm; two mirror-image nuclei (owl eyes) each with an eosinophilic nucleolus and a thick nuclear membrane (<a href="/wiki/Chromatin" title="Chromatin">chromatin</a> is distributed close to the nuclear membrane).</p>
<p>Variants:</p>
<ul>
<li><a href="/wiki/Hodgkin_cell" title="Hodgkin cell" class="mw-redirect">Hodgkin cell</a> (atypical mononuclear RSC) is a variant of RS cell, which has the same characteristics, but is mononucleated.</li>
<li>Lacunar RSC is large, with a single hyperlobulated nucleus, multiple, small nucleoli and eosinophilic cytoplasm which is retracted around the nucleus, creating an empty space ("lacunae").</li>
<li>Pleomorphic RSC has multiple irregular nuclei.</li>
<li>"Popcorn" RSC (lympho-histiocytic variant) is a small cell, with a very lobulated nucleus, small nucleoli.</li>
<li>"Mummy" RSC has a compact nucleus with no nucleolus and basophilic cytoplasm.</li>
</ul>
<p>Hodgkin's lymphoma can be sub-classified by histological type. The cell histology in Hodgkin's lymphoma is not as important as it is in <a href="/wiki/Non-Hodgkin%27s_lymphoma" title="Non-Hodgkin's lymphoma" class="mw-redirect">non-Hodgkin's lymphoma</a>: the treatment and prognosis in classic Hodgkin's lymphoma usually depends on the stage of disease rather than the <a href="/w/index.php?title=Histotype&amp;action=edit&amp;redlink=1" class="new" title="Histotype (page does not exist)">histotype</a>.</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=7" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Patients with early stage disease (IA or IIA) are effectively treated with <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> or chemotherapy. The choice of treatment depends on the age, sex, bulk and the histological subtype of the disease.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (September 2013)">citation needed</span></a></i>]</sup> Adding localised radiation therapy after the chemotherapy regimen controls the tumors better and provides a better chance for survival than chemotherapy alone.<sup id="cite_ref-pmid21328291_22-0" class="reference"><a href="#cite_note-pmid21328291-22"><span>[</span>22<span>]</span></a></sup> Patients with later disease (III, IVA, or IVB) are treated with <a href="/wiki/Combination_chemotherapy" title="Combination chemotherapy" class="mw-redirect">combination chemotherapy</a> alone. Patients of any stage with a large mass in the chest are usually treated with combined chemotherapy and radiation therapy.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (September 2013)">citation needed</span></a></i>]</sup></p>
<table class="wikitable">
<tr>
<th><a href="/wiki/MOPP_(chemotherapy)" title="MOPP (chemotherapy)">MOPP</a></th>
<th><a href="/wiki/ABVD" title="ABVD">ABVD</a></th>
<th><a href="/wiki/Stanford_V" title="Stanford V">Stanford V</a></th>
<th><a href="/wiki/BEACOPP" title="BEACOPP">BEACOPP</a></th>
</tr>
<tr>
<td>The original treatment for Hodgkin's was <i><a href="/wiki/MOPP_(medicine)" title="MOPP (medicine)" class="mw-redirect">MOPP (medicine)</a></i>. The abbreviation stands for the four drugs <a href="/wiki/Mustargen" title="Mustargen" class="mw-redirect">Mustargen</a>, <a href="/wiki/Oncovin" title="Oncovin" class="mw-redirect">Oncovin</a> (also known as Vincristine), <a href="/wiki/Prednisone" title="Prednisone">Prednisone</a> and <a href="/wiki/Procarbazine" title="Procarbazine">Procarbazine</a> (also known as Matulane). The treatment is usually administered in four week cycles, often for six cycles. MSD and VCR are administered intravenously, while procarbazine and prednisone are pills taken orally. MOPP was the first combination chemotherapy brought in that achieved a high success rate. It was developed at the National Cancer Institute in the 1960s by a team that included Vincent DeVita, Jr..
<p>Although no longer the most effective combination, MOPP is still used after relapse or where the patient has certain allergies or lung or heart problems which prevents the use of another regimen.</p>
</td>
<td>Currently, the <i><a href="/wiki/ABVD" title="ABVD">ABVD</a></i> <a href="/wiki/Chemotherapy_regimen" title="Chemotherapy regimen">chemotherapy regimen</a> is the standard treatment of Hodgkin's disease in the US. The abbreviation stands for the four drugs <a href="/wiki/Adriamycin" title="Adriamycin" class="mw-redirect">Adriamycin</a>, <a href="/wiki/Bleomycin" title="Bleomycin">bleomycin</a>, <a href="/wiki/Vinblastine" title="Vinblastine">vinblastine</a>, and <a href="/wiki/Dacarbazine" title="Dacarbazine">dacarbazine</a>. Developed in Italy in the 1970s, the ABVD treatment typically takes between six and eight months, although longer treatments may be required.</td>
<td>The newer <a href="/wiki/Stanford_V" title="Stanford V">Stanford V</a> regimen is typically only half as long as the ABVD but involves a more intensive chemotherapy schedule and incorporates radiation therapy. In a randomised controlled study in Italy, Stanford V was inferior to ABVD;<sup id="cite_ref-pmid16172458_23-0" class="reference"><a href="#cite_note-pmid16172458-23"><span>[</span>23<span>]</span></a></sup> however, this study has been heavily criticized due to its incorrect administration of radiotherapy, diverging from the original Stanford V protocol.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup></td>
<td><a href="/wiki/BEACOPP" title="BEACOPP">BEACOPP</a> is a form of treatment for stages &gt; II mainly used in Europe. The cure rate with the BEACOPP esc. regimen is approximately 10–15% higher than with standard ABVD in advanced stages. This was shown in a paper in The New England Journal of Medicine (Diehl et al.), but US physicians still favor ABVD, maybe because some physicians think that BEACOPP induces more secondary leukemia. However, this seems negligible compared to the higher cure rates. BEACOPP is more expensive because of the requirement for concurrent treatment with <a href="/wiki/GCSF" title="GCSF" class="mw-redirect">GCSF</a> to increase production of white blood cells. Currently, the German Hodgkin Study Group tests 8 cycles (8x) BEACOPP esc vs. 6x BEACOPP esc vs. 8x BEACOPP-14 baseline (HD15-trial).<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></td>
</tr>
<tr>
<td><a href="/wiki/Mustargen" title="Mustargen" class="mw-redirect">Mustargen</a></td>
<td><a href="/wiki/Doxorubicin" title="Doxorubicin">Doxorubicin</a></td>
<td><a href="/wiki/Doxorubicin" title="Doxorubicin">Doxorubicin</a></td>
<td><a href="/wiki/Doxorubicin" title="Doxorubicin">Doxorubicin</a></td>
</tr>
<tr>
<td><a href="/wiki/Oncovin" title="Oncovin" class="mw-redirect">Oncovin</a></td>
<td><a href="/wiki/Bleomycin" title="Bleomycin">Bleomycin</a></td>
<td><a href="/wiki/Bleomycin" title="Bleomycin">Bleomycin</a></td>
<td><a href="/wiki/Bleomycin" title="Bleomycin">Bleomycin</a></td>
</tr>
<tr>
<td><a href="/wiki/Vincristine" title="Vincristine">Vincristine</a></td>
<td><a href="/wiki/Vinblastine" title="Vinblastine">Vinblastine</a></td>
<td><a href="/wiki/Vinblastine" title="Vinblastine">Vinblastine</a>, <a href="/wiki/Vincristine" title="Vincristine">Vincristine</a></td>
<td><a href="/wiki/Vincristine" title="Vincristine">Vincristine</a></td>
</tr>
<tr>
<td><a href="/wiki/Vinblastine" title="Vinblastine">Vinblastine</a></td>
<td><a href="/wiki/Dacarbazine" title="Dacarbazine">Dacarbazine</a></td>
<td><a href="/wiki/Mechlorethamine" title="Mechlorethamine" class="mw-redirect">Mechlorethamine</a></td>
<td><a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a>, <a href="/wiki/Procarbazine" title="Procarbazine">Procarbazine</a></td>
</tr>
<tr>
<td></td>
<td><a href="/wiki/Etoposide" title="Etoposide">Etoposide</a></td>
<td><a href="/wiki/Etoposide" title="Etoposide">Etoposide</a></td>
</tr>
<tr>
<td></td>
<td><a href="/wiki/Prednisone" title="Prednisone">Prednisone</a></td>
<td><a href="/wiki/Prednisone" title="Prednisone">Prednisone</a></td>
</tr>
</table>
<p>It should be noted that the common non-Hodgkin's treatment, <a href="/wiki/Rituximab" title="Rituximab">rituximab</a> (which is a monoclonal antibody against CD20) is not routinely used to treat Hodgkin's lymphoma due to the lack of CD20 surface antigens in most cases. The use of rituximab in Hodgkin's lymphoma, including the lymphocyte predominant subtype has been reviewed recently.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup></p>
<p>Although increased age is an adverse risk factor for Hodgkin's lymphoma, in general elderly patients without major comorbidities are sufficiently fit to tolerate standard therapy, and have a treatment outcome comparable to that of younger patients. However, the disease is a different entity in older patients and different considerations enter into treatment decisions.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></p>
<p>For Hodgkin's lymphomas, radiation oncologists typically use <a href="/wiki/External_beam_radiation_therapy" title="External beam radiation therapy" class="mw-redirect">external beam radiation therapy</a> (sometimes shortened to EBRT or XRT). Radiation oncologists deliver external beam radiation therapy to the lymphoma from a machine called a linear accelerator. Patients usually describe treatments as painless and similar to getting an X-ray. Treatments last less than 30 minutes each, every day but Saturday and Sunday.</p>
<p>For lymphomas, there are a few different ways radiation oncologists target the cancer cells. Involved field radiation is when the radiation oncologists give radiation only to those parts of the patient's body known to have the cancer. Very often, this is combined with chemotherapy. Radiation therapy directed above the diaphragm to the neck, chest and/or underarms is called mantle field radiation. Radiation to below the diaphragm to the abdomen, spleen and/or pelvis is called inverted-Y field radiation. Total nodal irradiation is when the therapist gives radiation to all the lymph nodes in the body to destroy cells that may have spread.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Adverse_effects">Adverse effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=8" title="Edit section: Adverse effects">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The high cure rates and long survival of many patients with Hodgkin's lymphoma has led to a high concern with late adverse effects of treatment, including cardiovascular disease and second malignancies such as acute <a href="/wiki/Leukemia" title="Leukemia">leukemias</a>, lymphomas, and <a href="/wiki/Solid_tumors" title="Solid tumors" class="mw-redirect">solid tumors</a> within the radiation therapy field. Most patients with early-stage disease are now treated with abbreviated chemotherapy and involved-field radiation therapy rather than with radiation therapy alone. Clinical research strategies are exploring reduction of the duration of chemotherapy and dose and volume of radiation therapy in an attempt to reduce late morbidity and mortality of treatment while maintaining high cure rates. Hospitals are also treating those who respond quickly to chemotherapy with no radiation.</p>
<p>In childhood cases of Hodgkin's lymphoma, long-term endocrine adverse effects are a major concern, mainly <a href="/w/index.php?title=Gonadal_dysfunction&amp;action=edit&amp;redlink=1" class="new" title="Gonadal dysfunction (page does not exist)">gonadal dysfunction</a> and <a href="/wiki/Growth_retardation" title="Growth retardation" class="mw-redirect">growth retardation</a>. Gonadal dysfunction seems to be the most severe endocrine long-term effect, especially after treatment with <a href="/wiki/Alkylating_agent" title="Alkylating agent" class="mw-redirect">alkylating agents</a> and/or pelvic radiotherapy.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=9" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Treatment of Hodgkin's disease has been improving over the past few decades. Recent trials that have made use of new types of chemotherapy have indicated higher survival rates than have previously been seen. In one recent European trial, the 5-year survival rate for those patients with a favorable prognosis was 98%, while that for patients with worse outlooks was at least 85%.<sup id="cite_ref-Ferm_30-0" class="reference"><a href="#cite_note-Ferm-30"><span>[</span>30<span>]</span></a></sup></p>
<p>In 1998, an international effort<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> identified seven prognostic factors that accurately predict the success rate of conventional treatment in patients with locally extensive or advanced stage Hodgkin's lymphoma. Freedom from progression (FFP) at 5 years was directly related to the number of factors present in a patient. The 5-year FFP for patients with zero factors is 84%. Each additional factor lowers the 5-year FFP rate by 7%, such that the 5-year FFP for a patient with 5 or more factors is 42%.</p>
<p>The adverse prognostic factors identified in the international study are:</p>
<ul>
<li>Age ≥ 45 years</li>
<li>Stage IV disease</li>
<li><a href="/wiki/Hemoglobin" title="Hemoglobin">Hemoglobin</a> &lt; 10.5 g/dl</li>
<li><a href="/wiki/Lymphocyte_count" title="Lymphocyte count" class="mw-redirect">Lymphocyte count</a> &lt; 600/µl or &lt; 8%</li>
<li><a href="/wiki/Male" title="Male">Male</a></li>
<li><a href="/wiki/Albumin" title="Albumin">Albumin</a> &lt; 4.0 g/dl</li>
<li><a href="/wiki/White_blood_cell_count" title="White blood cell count" class="mw-redirect">White blood count</a> ≥ 15,000/µl</li>
</ul>
<p>Other studies have reported the following to be the most important adverse prognostic factors: mixed-cellularity or lymphocyte-depleted histologies, male sex, large number of involved nodal sites, advanced stage, age of 40 years or more, the presence of B symptoms, high <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a>, and bulky disease (widening of the <a href="/wiki/Mediastinum" title="Mediastinum">mediastinum</a> by more than one third, or the presence of a nodal mass measuring more than 10&#160;cm in any dimension.)</p>
<p>More recently, use of positron emission tomography (PET) early after commencing chemotherapy has demonstrated to have powerful prognostic ability.<sup id="cite_ref-pmid23516309_32-0" class="reference"><a href="#cite_note-pmid23516309-32"><span>[</span>32<span>]</span></a></sup> This enables assessment of an individuals response to chemotherapy as the PET activity switches off rapidly in patients who are responding. In this study,<sup id="cite_ref-pmid23516309_32-1" class="reference"><a href="#cite_note-pmid23516309-32"><span>[</span>32<span>]</span></a></sup> after two cycles of ABVD chemotherapy, 83% of patients were free of disease at 3 years if they had a negative PET versus only 28% in those with positive PET scans. This prognostic power exceeds conventional factors discussed above. Several trials are underway to see if PET-based risk adapted response can be used to improve patient outcomes by changing chemotherapy early in patients who are not responding.</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=10" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Lymphomas,_multiple_myeloma_world_map_-_Death_-_WHO2004.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Lymphomas%2C_multiple_myeloma_world_map_-_Death_-_WHO2004.svg/220px-Lymphomas%2C_multiple_myeloma_world_map_-_Death_-_WHO2004.svg.png" width="220" height="97" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Lymphomas%2C_multiple_myeloma_world_map_-_Death_-_WHO2004.svg/330px-Lymphomas%2C_multiple_myeloma_world_map_-_Death_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Lymphomas%2C_multiple_myeloma_world_map_-_Death_-_WHO2004.svg/440px-Lymphomas%2C_multiple_myeloma_world_map_-_Death_-_WHO2004.svg.png 2x" data-file-width="940" data-file-height="415" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Lymphomas,_multiple_myeloma_world_map_-_Death_-_WHO2004.svg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Age_adjustment" title="Age adjustment">Age-standardized</a> death from <a href="/wiki/Lymphomas" title="Lymphomas" class="mw-redirect">lymphomas</a> and <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a> per 100,000&#160;inhabitants in 2004<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup>
<div class="refbegin columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;no data</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;less than 1.8</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;1.8–3.6</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;3.6–5.4</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;5.4–7.2</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;7.2–9</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;9–10.8</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;10.8–12.6</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;12.6–14.4</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;14.4–16.2</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;16.2–18</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;18–19.8</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;more than 19.8</div>
</div>
</div>
</div>
</div>
<p>Unlike some <a href="/wiki/Non-Hodgkin_lymphoma" title="Non-Hodgkin lymphoma">other lymphomas</a>, whose <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> increases with age, Hodgkin's lymphoma has a <a href="/wiki/Bimodal_distribution" title="Bimodal distribution" class="mw-redirect">bimodal</a> incidence curve; that is, it occurs most frequently in two separate age groups, the first being young adulthood (age 15–35) and the second being in those over 55 years old although these peaks may vary slightly with nationality.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup> Overall, it is more common in males, except for the <a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">nodular sclerosis</a> variant, which is slightly more common in females. The annual incidence of Hodgkin's lymphoma is 2.7 per 100,000 per persons per year, and the disease accounts for slightly less than 1% of all cancers worldwide.<sup id="cite_ref-SEER_2014_35-0" class="reference"><a href="#cite_note-SEER_2014-35"><span>[</span>35<span>]</span></a></sup></p>
<p>In 2010, globally it resulted in about 18,000 deaths down from 19,000 in 1990.<sup id="cite_ref-Lozano_2012_2-1" class="reference"><a href="#cite_note-Lozano_2012-2"><span>[</span>2<span>]</span></a></sup></p>
<p>The incidence of Hodgkin's lymphoma is increased in patients with <a href="/wiki/HIV" title="HIV">HIV</a> infection.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup> In contrast to many other lymphomas associated with HIV infection it occurs most commonly in patients with higher <a href="/wiki/CD4" title="CD4">CD4</a> T cell counts.</p>
<h3><span class="mw-headline" id="UK">UK</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=11" title="Edit section: UK">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Hodgkin lymphoma accounts for less than 1% of all cancer cases and deaths in the UK. Around 1,800 people were diagnosed with the disease in 2011, and around 330 people died in 2012.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=12" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Hodgkin%27s_Disease_(Essentials_of_Medicine).jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Hodgkin%27s_Disease_%28Essentials_of_Medicine%29.jpg/180px-Hodgkin%27s_Disease_%28Essentials_of_Medicine%29.jpg" width="180" height="269" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Hodgkin%27s_Disease_%28Essentials_of_Medicine%29.jpg/270px-Hodgkin%27s_Disease_%28Essentials_of_Medicine%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Hodgkin%27s_Disease_%28Essentials_of_Medicine%29.jpg/360px-Hodgkin%27s_Disease_%28Essentials_of_Medicine%29.jpg 2x" data-file-width="1268" data-file-height="1895" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Hodgkin%27s_Disease_(Essentials_of_Medicine).jpg" class="internal" title="Enlarge"></a></div>
Photograph from a 1938 medical textbook labeled "Hodgkin's Disease", (<i>Essentials of medicine</i>)</div>
</div>
</div>
<p>Hodgkin's lymphoma was first described in an 1832 report by <a href="/wiki/Thomas_Hodgkin" title="Thomas Hodgkin">Thomas Hodgkin</a>, although Hodgkin noted that perhaps the earliest reference to the condition was provided by <a href="/wiki/Marcello_Malpighi" title="Marcello Malpighi">Marcello Malpighi</a> in 1666.<sup id="cite_ref-Hoppe2007_8-1" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-Hodgkin1832_9-1" class="reference"><a href="#cite_note-Hodgkin1832-9"><span>[</span>9<span>]</span></a></sup> While occupied as museum curator at <a href="/wiki/Guy%27s_Hospital" title="Guy's Hospital">Guy's Hospital</a>, Hodgkin studied seven patients with painless lymph node enlargement. Of the seven cases, two were patients of <a href="/wiki/Richard_Bright_(physician)" title="Richard Bright (physician)">Richard Bright</a>, one was of <a href="/wiki/Thomas_Addison" title="Thomas Addison">Thomas Addison</a>, and one was of <a href="/wiki/Robert_Carswell_(pathologist)" title="Robert Carswell (pathologist)">Robert Carswell</a>.<sup id="cite_ref-Hoppe2007_8-2" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup> Carswell's report of this seventh patient was accompanied by numerous illustrations that aided early descriptions of the disease.<sup id="cite_ref-pmid10594291_38-0" class="reference"><a href="#cite_note-pmid10594291-38"><span>[</span>38<span>]</span></a></sup></p>
<p>Hodgkin's report on these seven patients, entitled "On some morbid appearances of the absorbent glands and spleen", was presented to the <a href="/w/index.php?title=Medical_and_Chirurgical_Society&amp;action=edit&amp;redlink=1" class="new" title="Medical and Chirurgical Society (page does not exist)">Medical and Chirurgical Society</a> in London in January 1832 and was subsequently published in the society's journal, <i>Medical-Chirurgical Society Transactions</i>.<sup id="cite_ref-Hoppe2007_8-3" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup> Hodgkin's paper went largely unnoticed, however, even despite Bright highlighting it in an 1838 publication.<sup id="cite_ref-Hoppe2007_8-4" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup> Indeed, Hodgkin himself did not view his contribution as particularly significant.<sup id="cite_ref-Geller1984_39-0" class="reference"><a href="#cite_note-Geller1984-39"><span>[</span>39<span>]</span></a></sup></p>
<p>In 1856, <a href="/wiki/Samuel_Wilks" title="Samuel Wilks">Samuel Wilks</a> independently reported on a series of patients with the same disease that Hodgkin had previously described.<sup id="cite_ref-Geller1984_39-1" class="reference"><a href="#cite_note-Geller1984-39"><span>[</span>39<span>]</span></a></sup> Wilks, a successor to Hodgkin at Guy's Hospital, was unaware of Hodgkin's prior work on the subject. Bright made Wilks aware of Hodgkin's contribution and in 1865, Wilks published a second paper, entitled "Cases of enlargement of the lymphatic glands and spleen", in which he called the disease "Hodgkin's disease" in honor of his predecessor.<sup id="cite_ref-Geller1984_39-2" class="reference"><a href="#cite_note-Geller1984-39"><span>[</span>39<span>]</span></a></sup></p>
<p><a href="/wiki/Theodor_Langhans" title="Theodor Langhans">Theodor Langhans</a> and WS Greenfield first described the microscopic characteristics of Hodgkin's lymphoma in 1872 and 1878, respectively.<sup id="cite_ref-Hoppe2007_8-5" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup> In 1898 and 1902, respectively, <a href="/w/index.php?title=Carl_Sternberg&amp;action=edit&amp;redlink=1" class="new" title="Carl Sternberg (page does not exist)">Carl Sternberg</a> and <a href="/wiki/Dorothy_Mabel_Reed_Mendenhall" title="Dorothy Mabel Reed Mendenhall" class="mw-redirect">Dorothy Reed</a> independently described the cytogenetic features of the malignant cells of Hodgkin's lymphoma, now called Reed–Sternberg cells.<sup id="cite_ref-Hoppe2007_8-6" class="reference"><a href="#cite_note-Hoppe2007-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Tissue specimens from Hodgkin's seven patients remained at Guy's Hospital for a number of years. Nearly 100 years after Hodgkin's initial publication, <a href="/wiki/Histopathology" title="Histopathology">histopathologic</a> reexamination confirmed Hodgkin's lymphoma in only three of seven of these patients.<sup id="cite_ref-Geller1984_39-3" class="reference"><a href="#cite_note-Geller1984-39"><span>[</span>39<span>]</span></a></sup> The remaining cases included <a href="/wiki/Non-Hodgkin_lymphoma" title="Non-Hodgkin lymphoma">non-Hodgkin lymphoma</a>, <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a>, and <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>.<sup id="cite_ref-Geller1984_39-4" class="reference"><a href="#cite_note-Geller1984-39"><span>[</span>39<span>]</span></a></sup></p>
<p>Hodgkin's lymphoma was one of the first cancers which could be treated using <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> and, later, it was one of the first to be treated by <a href="/wiki/Combination_chemotherapy" title="Combination chemotherapy" class="mw-redirect">combination chemotherapy</a>.</p>
<h2><span class="mw-headline" id="Notable_cases">Notable cases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=13" title="Edit section: Notable cases">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="mbox-small plainlinks sistersitebox" style="border:1px solid #aaa;background-color:#f9f9f9">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/40px-Wikinews-logo.svg.png" width="40" height="22" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/60px-Wikinews-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/80px-Wikinews-logo.svg.png 2x" data-file-width="759" data-file-height="415" /></td>
<td class="mbox-text plainlist">Wikinews has related news:
<ul>
<li><i><b><a href="//en.wikinews.org/wiki/Mother_and_son_disappear_after_court_orders_cancer_treatment" class="extiw" title="wikinews:Mother and son disappear after court orders cancer treatment">Mother and son disappear after court orders cancer treatment</a></b></i></li>
<li><i><b><a href="//en.wikinews.org/wiki/Court_rules_teen_must_take_chemotherapy" class="extiw" title="wikinews:Court rules teen must take chemotherapy">Court rules teen must take chemotherapy</a></b></i></li>
</ul>
</td>
</tr>
</table>
<ul>
<li><a href="/wiki/Mario_Lemieux" title="Mario Lemieux">Mario Lemieux</a>, Hall of Fame NHL player, co-owner of the <a href="/wiki/Pittsburgh_Penguins" title="Pittsburgh Penguins">Pittsburgh Penguins</a> and founder of the Mario Lemieux Foundation<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup></li>
<li><a href="/wiki/Howard_Carter" title="Howard Carter">Howard Carter</a>, Egyptologist and discoverer of the Tomb of <a href="/wiki/Tutankhamun" title="Tutankhamun">Tutankhamun</a>, died in 1939 from Hodgkin's disease.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup></li>
<li><a href="/wiki/Lynden_David_Hall" title="Lynden David Hall">Lynden David Hall</a>, British singer and songwriter, died on 14 February 2006, at the age of 31, from complications resulting from a stem cell transplant for Hodgkin's lymphoma. Hall was in remission at the time of his death.</li>
<li><a href="/wiki/Virginia_v._Cherrix" title="Virginia v. Cherrix">Starchild Abraham Cherrix</a>, a teenager whose refusal to undergo further conventional treatment after relapsing resulted in a court battle and a change to Virginia laws about medical neglect.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup></li>
<li>Daniel Hauser, whose mother fled with him in order to prevent him from undergoing chemotherapy.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup></li>
<li>American singer and guitarist <a href="/wiki/Glen_Goins" title="Glen Goins" class="mw-redirect">Glen Goins</a> died of the disease in 1978.</li>
<li>Australian singer <a href="/wiki/Delta_Goodrem" title="Delta Goodrem">Delta Goodrem</a> was diagnosed in 2003. She was admitted to hospital to have treatment for the disease after having finished filming of T.V show Neighbors. The diagnosis caused mass hysteria around the world, with tabloid papers in the UK and Australia dubbing it the "Delta Affect". The year 2003 saw Delta have the highest selling, and longest running album at #1 on the charts in more than a decade. The year also saw her win an unprecedented 7 ARIA awards (Australian Grammy's) for her 15x Platinum Album Innocent Eyes. The album spawned 5 #1 singles, all reaching platinum or better certification.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45"><span>[</span>45<span>]</span></a></sup></li>
<li>Irish actor <a href="/wiki/Richard_Harris" title="Richard Harris">Richard Harris</a>, who portrayed <a href="/wiki/Albus_Dumbledore" title="Albus Dumbledore">Albus Dumbledore</a> in the first two <a href="/wiki/Harry_Potter_(film_series)" title="Harry Potter (film series)">Harry Potter movies</a>.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup></li>
<li><a href="/wiki/Anthony_Rizzo_(baseball)" title="Anthony Rizzo (baseball)" class="mw-redirect">Anthony Rizzo</a>, MLB All-Star <a href="/wiki/First_baseman" title="First baseman">first baseman</a> for the <a href="/wiki/Chicago_Cubs" title="Chicago Cubs">Chicago Cubs</a>, May 2008 as a minor league player for the <a href="/wiki/Red_Sox" title="Red Sox" class="mw-redirect">Red Sox</a>.</li>
<li><a href="/wiki/Dinu_Lipatti" title="Dinu Lipatti">Dinu Lipatti</a> (1917–1950), Romanian classical pianist and composer.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup></li>
<li><a href="/wiki/Eric_Berry" title="Eric Berry">Eric Berry</a>, All-pro strong safety for the <a href="/wiki/Kansas_City_Chiefs" title="Kansas City Chiefs">Kansas City Chiefs</a> of the <a href="/wiki/National_Football_League" title="National Football League">National Football League</a><sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></li>
<li><a href="/wiki/Paul_Allen" title="Paul Allen">Paul Allen</a>, co-founder of Microsoft. Recovered from the disease.</li>
<li><a href="/wiki/Michael_C._Hall" title="Michael C. Hall">Michael C. Hall</a> (born February 1, 1971) American actor, best known for his lead role as <a href="/wiki/Dexter_Morgan" title="Dexter Morgan">Dexter Morgan</a>, in Showtime's crime series <i><a href="/wiki/Dexter_(TV_series)" title="Dexter (TV series)">Dexter</a></i>. At age 38, Hall announced he was undergoing treatment for Hodgkin's Lymphoma; within two years, the disease was in full remission.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=14" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/ABVD" title="ABVD">ABVD</a></li>
<li><a href="/wiki/Ann_Arbor_staging" title="Ann Arbor staging">Ann Arbor staging</a></li>
<li><a href="/wiki/List_of_hematologic_conditions" title="List of hematologic conditions">List of hematologic conditions</a></li>
<li><a href="/wiki/Lymphadenopathy" title="Lymphadenopathy">Lymphadenopathy</a></li>
<li><a href="/wiki/Non-Hodgkin_lymphoma" title="Non-Hodgkin lymphoma">Non-Hodgkin lymphoma</a>, an outdated classification scheme for <a href="/wiki/Lymphomas" title="Lymphomas" class="mw-redirect">lymphomas</a></li>
<li><a href="/wiki/Progressive_transformation_of_germinal_centres" title="Progressive transformation of germinal centres">Progressive transformation of germinal centres</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=15" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><span class="citation book"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=PoFJ-OhE63UC&amp;pg=PA97"><i>Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers</i></a>. Cambridge University Press. 1994. pp.&#160;97–. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-521-47154-1" title="Special:BookSources/978-0-521-47154-1">978-0-521-47154-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Scientific+Style+and+Format%3A+The+CBE+Manual+for+Authors%2C+Editors%2C+and+Publishers&amp;rft.date=1994&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DPoFJ-OhE63UC%26pg%3DPA97&amp;rft.isbn=978-0-521-47154-1&amp;rft.pages=97-&amp;rft.pub=Cambridge+University+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lozano_2012-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lozano_2012_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lozano_2012_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al. (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.". <i>Lancet</i> <b>380</b> (9859): 2095–128. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2812%2961728-0">10.1016/S0140-6736(12)61728-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23245604">23245604</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Global+and+regional+mortality+from+235+causes+of+death+for+20+age+groups+in+1990+and+2010%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2010.&amp;rft.aulast=Lozano+R%2C+Naghavi+M%2C+Foreman+K%2C+Lim+S%2C+Shibuya+K%2C+Aboyans+V&amp;rft.au=Lozano+R%2C+Naghavi+M%2C+Foreman+K%2C+Lim+S%2C+Shibuya+K%2C+Aboyans+V&amp;rft.date=Dec+15%2C+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2812%2961728-0&amp;rft_id=info%3Apmid%2F23245604&amp;rft.issue=9859&amp;rft.jtitle=Lancet&amp;rft.pages=2095-128&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=380" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Flavell, K J; Murray, P G (2000). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1186979">"Hodgkin's disease and the Epstein–Barr virus"</a>. <i>Molecular Pathology</i> <b>53</b> (5): 262–269. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fmp.53.5.262">10.1136/mp.53.5.262</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1186979">1186979</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11091850">11091850</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Hodgkin%27s+disease+and+the+Epstein%E2%80%93Barr+virus&amp;rft.aufirst=K+J&amp;rft.au=Flavell%2C+K+J&amp;rft.aulast=Flavell&amp;rft.au=Murray%2C+P+G&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1186979&amp;rft_id=info%3Adoi%2F10.1136%2Fmp.53.5.262&amp;rft_id=info%3Apmc%2F1186979&amp;rft_id=info%3Apmid%2F11091850&amp;rft.issue=5&amp;rft.jtitle=Molecular+Pathology&amp;rft.pages=262-269&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Gandhi MK, Tellam JT, Khanna R (May 2004). "Epstein-Barr virus-associated Hodgkin's lymphoma.". <i>Br J Haematol.</i> <b>125</b> (3): 267–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2141.2004.04902.x">10.1111/j.1365-2141.2004.04902.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15086409">15086409</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Epstein-Barr+virus-associated+Hodgkin%27s+lymphoma.&amp;rft.au=Gandhi+MK%2C+Tellam+JT%2C+Khanna+R&amp;rft.aulast=Gandhi+MK%2C+Tellam+JT%2C+Khanna+R&amp;rft.date=May+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2004.04902.x&amp;rft_id=info%3Apmid%2F15086409&amp;rft.issue=3&amp;rft.jtitle=Br+J+Haematol.&amp;rft.pages=267-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=125" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-seer-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-seer_5-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://seer.cancer.gov/statfacts/html/hodg.html">"Hodgkin Lymphoma—SEER Stat Fact Sheets"</a>. Seer.cancer.gov<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-08-26</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Hodgkin+Lymphoma%E2%80%94SEER+Stat+Fact+Sheets&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fhodg.html&amp;rft.pub=Seer.cancer.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Armitage2010-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Armitage2010_6-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Armitage JO (August 2010). <a rel="nofollow" class="external text" href="http://www.nejm.org/doi/full/10.1056/NEJMra1003733">"Early-stage Hodgkin's Lymphoma"</a>. <i>N. Engl. J. Med.</i> <b>363</b> (7): 653–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra1003733">10.1056/NEJMra1003733</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20818856">20818856</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Early-stage+Hodgkin%27s+Lymphoma&amp;rft.au=Armitage+JO&amp;rft.aulast=Armitage+JO&amp;rft.date=August+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMra1003733&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra1003733&amp;rft_id=info%3Apmid%2F20818856&amp;rft.issue=7&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=653-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text">Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) <a rel="nofollow" class="external text" href="http://canques.seer.cancer.gov/cgi-bin/cq_submit?dir=seer2006&amp;db=4&amp;rpt=LINE&amp;sel=1^0^79^0^^^&amp;x=Age%20at%20diagnosis^6,7,8,9,10,11,12,13,14,15,16,17,18,19,20&amp;y=Race^0,1,2^Sex^0,1,2&amp;dec=1&amp;template=null">Cancer.gov</a></span></li>
<li id="cite_note-Hoppe2007-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hoppe2007_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hoppe2007_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Hoppe2007_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Hoppe2007_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Hoppe2007_8-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Hoppe2007_8-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Hoppe2007_8-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Hellman S (2007). "Brief Consideration of Thomas Hodgkin and His Times". In Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM. <i>Hodgkin Lymphoma</i> (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins. pp.&#160;3–6. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-6422-X" title="Special:BookSources/0-7817-6422-X">0-7817-6422-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Brief+Consideration+of+Thomas+Hodgkin+and+His+Times&amp;rft.au=Hellman+S&amp;rft.aulast=Hellman+S&amp;rft.btitle=Hodgkin+Lymphoma&amp;rft.date=2007&amp;rft.edition=2nd&amp;rft.genre=bookitem&amp;rft.isbn=0-7817-6422-X&amp;rft.pages=3-6&amp;rft.place=Philadelphia&amp;rft.pub=Wolters+Kluwer+Health%2FLippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hodgkin1832-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hodgkin1832_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hodgkin1832_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hodgkin T (1832). "On some morbid experiences of the absorbent glands and spleen". <i>Med Chir Trans</i> <b>17</b>: 69–97.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=On+some+morbid+experiences+of+the+absorbent+glands+and+spleen&amp;rft.au=Hodgkin+T&amp;rft.aulast=Hodgkin+T&amp;rft.date=1832&amp;rft.genre=article&amp;rft.jtitle=Med+Chir+Trans&amp;rft.pages=69-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlHMDS:_Hodgkins_Lymphoma-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-urlHMDS:_Hodgkins_Lymphoma_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-urlHMDS:_Hodgkins_Lymphoma_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.hmds.org.uk/hl.html">"HMDS: Hodgkin's Lymphoma"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">February 1,</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=HMDS%3A+Hodgkin%27s+Lymphoma&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.hmds.org.uk%2Fhl.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12078890-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12078890_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Küppers R, Schwering I, Bräuninger A, Rajewsky K, Hansmann ML (2002). <a rel="nofollow" class="external text" href="http://annonc.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12078890">"Biology of Hodgkin's lymphoma"</a>. <i>Annals of Oncology</i>. 13 Suppl 1: 11–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fannonc%2F13.S1.11">10.1093/annonc/13.S1.11</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12078890">12078890</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Biology+of+Hodgkin%27s+lymphoma&amp;rft.au=K%C3%BCppers+R%2C+Schwering+I%2C+Br%C3%A4uninger+A%2C+Rajewsky+K%2C+Hansmann+ML&amp;rft.aulast=K%C3%BCppers+R%2C+Schwering+I%2C+Br%C3%A4uninger+A%2C+Rajewsky+K%2C+Hansmann+ML&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fannonc.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D12078890&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2F13.S1.11&amp;rft_id=info%3Apmid%2F12078890&amp;rft.jtitle=Annals+of+Oncology&amp;rft.pages=11-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13+Suppl+1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16385563-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16385563_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bräuninger A, Schmitz R, Bechtel D, Renné C, Hansmann ML, Küppers R (April 2006). "Molecular biology of Hodgkin's and Reed–Sternberg cells in Hodgkin's lymphoma". <i>Int. J. Cancer</i> <b>118</b> (8): 1853–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fijc.21716">10.1002/ijc.21716</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16385563">16385563</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Molecular+biology+of+Hodgkin%27s+and+Reed%E2%80%93Sternberg+cells+in+Hodgkin%27s+lymphoma&amp;rft.au=Br%C3%A4uninger+A%2C+Schmitz+R%2C+Bechtel+D%2C+Renn%C3%A9+C%2C+Hansmann+ML%2C+K%C3%BCppers+R&amp;rft.aulast=Br%C3%A4uninger+A%2C+Schmitz+R%2C+Bechtel+D%2C+Renn%C3%A9+C%2C+Hansmann+ML%2C+K%C3%BCppers+R&amp;rft.date=April+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.21716&amp;rft_id=info%3Apmid%2F16385563&amp;rft.issue=8&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.pages=1853-61&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16056244-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16056244_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tzankov A, Bourgau C, Kaiser A, Zimpfer A, Maurer R, Pileri SA, Went P, Dirnhofer S (December 2005). "Rare expression of T-cell markers in classical Hodgkin's lymphoma". <i>Mod. Pathol.</i> <b>18</b> (12): 1542–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fmodpathol.3800473">10.1038/modpathol.3800473</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16056244">16056244</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Rare+expression+of+T-cell+markers+in+classical+Hodgkin%27s+lymphoma&amp;rft.aulast=Tzankov+A%2C+Bourgau+C%2C+Kaiser+A%2C+Zimpfer+A%2C+Maurer+R%2C+Pileri+SA%2C+Went+P%2C+Dirnhofer+S&amp;rft.au=Tzankov+A%2C+Bourgau+C%2C+Kaiser+A%2C+Zimpfer+A%2C+Maurer+R%2C+Pileri+SA%2C+Went+P%2C+Dirnhofer+S&amp;rft.date=December+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.3800473&amp;rft_id=info%3Apmid%2F16056244&amp;rft.issue=12&amp;rft.jtitle=Mod.+Pathol.&amp;rft.pages=1542-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-blood-112-8-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-blood-112-8_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lamprecht B, Kreher S, Anagnostopoulos I, Jöhrens K, Monteleone G, Jundt F, Stein H, Janz M, Dörken B, Mathas S (2008). <a rel="nofollow" class="external text" href="http://bloodjournal.hematologylibrary.org/cgi/content/abstract/112/8/3339">"Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3a"</a>. <i>Blood</i> <b>112</b> (Oct 2008): 3339–3347. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-01-134783">10.1182/blood-2008-01-134783</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18684866">18684866</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Aberrant+expression+of+the+Th2+cytokine+IL-21+in+Hodgkin+lymphoma+cells+regulates+STAT3+signaling+and+attracts+Treg+cells+via+regulation+of+MIP-3a&amp;rft.au=Lamprecht+B%2C+Kreher+S%2C+Anagnostopoulos+I%2C+J%C3%B6hrens+K%2C+Monteleone+G%2C+Jundt+F%2C+Stein+H%2C+Janz+M%2C+D%C3%B6rken+B%2C+Mathas+S&amp;rft.aulast=Lamprecht+B%2C+Kreher+S%2C+Anagnostopoulos+I%2C+J%C3%B6hrens+K%2C+Monteleone+G%2C+Jundt+F%2C+Stein+H%2C+Janz+M%2C+D%C3%B6rken+B%2C+Mathas+S&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Fabstract%2F112%2F8%2F3339&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-01-134783&amp;rft_id=info%3Apmid%2F18684866&amp;rft.issue=Oct+2008&amp;rft.jtitle=Blood&amp;rft.pages=3339-3347&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=112" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Hofman MS, Smeeton NC, Rankin SC, Nunan T, O'Doherty MJ (2009). "Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging". <i>Journal of Nuclear Medicine</i> <b>50</b> (10): 1594–1597. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2967%2Fjnumed.109.064121">10.2967/jnumed.109.064121</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19759113">19759113</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Observer+Variation+in+Interpreting+18F-FDG+PET%2FCT+Findings+for+Lymphoma+Staging&amp;rft.au=Hofman+MS%2C+Smeeton+NC%2C+Rankin+SC%2C+Nunan+T%2C+O%27Doherty+MJ&amp;rft.aulast=Hofman+MS%2C+Smeeton+NC%2C+Rankin+SC%2C+Nunan+T%2C+O%27Doherty+MJ&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2967%2Fjnumed.109.064121&amp;rft_id=info%3Apmid%2F19759113&amp;rft.issue=10&amp;rft.jtitle=Journal+of+Nuclear+Medicine&amp;rft.pages=1594-1597&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Bobrove AM (June 1983). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1010854">"Alcohol-related pain and Hodgkin's disease"</a>. <i>The Western Journal of Medicine</i> <b>138</b> (6): 874–5. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1010854">1010854</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6613116">6613116</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Alcohol-related+pain+and+Hodgkin%27s+disease&amp;rft.au=Bobrove+AM&amp;rft.aulast=Bobrove+AM&amp;rft.date=June+1983&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1010854&amp;rft_id=info%3Apmc%2F1010854&amp;rft_id=info%3Apmid%2F6613116&amp;rft.issue=6&amp;rft.jtitle=The+Western+Journal+of+Medicine&amp;rft.pages=874-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=138" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kearsley1998-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kearsley1998_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kearsley1998_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kearsley1998_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Kearsley1998_17-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=SkWAmFkK-7cC&amp;pg=PA242">Page 242</a> in: <span class="citation book">John Kearsley (1998). <i>Cancer: A Comprehensive Clinical Guide</i>. Washington, DC: Taylor &amp; Francis. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/90-5702-215-X" title="Special:BookSources/90-5702-215-X">90-5702-215-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.au=John+Kearsley&amp;rft.aulast=John+Kearsley&amp;rft.btitle=Cancer%3A+A+Comprehensive+Clinical+Guide&amp;rft.date=1998&amp;rft.genre=book&amp;rft.isbn=90-5702-215-X&amp;rft.place=Washington%2C+DC&amp;rft.pub=Taylor+%26+Francis&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation web">Portlock CS (July 2008). <a rel="nofollow" class="external text" href="http://www.merck.com/mmpe/sec11/ch143/ch143b.html">"Hodgkin Lymphoma"</a>. <i>Merck Manual Professional</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Hodgkin+Lymphoma&amp;rft.aulast=Portlock+CS&amp;rft.au=Portlock+CS&amp;rft.date=July+2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.merck.com%2Fmmpe%2Fsec11%2Fch143%2Fch143b.html&amp;rft.jtitle=Merck+Manual+Professional&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation book">Hodgon DC, Gospodarowicz MK (2007). "Clinical Evaluation and Staging of Hodgkin Lymphoma". In Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM. <i>Hodgkin’s disease</i> (2nd ed.). Lippincott Williams &amp; Wilkins. pp.&#160;123–132. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-6422-3" title="Special:BookSources/978-0-7817-6422-3">978-0-7817-6422-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Clinical+Evaluation+and+Staging+of+Hodgkin+Lymphoma&amp;rft.au=Hodgon+DC%2C+Gospodarowicz+MK&amp;rft.aulast=Hodgon+DC%2C+Gospodarowicz+MK&amp;rft.btitle=Hodgkin%E2%80%99s+disease&amp;rft.date=2007&amp;rft.edition=2nd&amp;rft.genre=bookitem&amp;rft.isbn=978-0-7817-6422-3&amp;rft.pages=123-132&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Hilson AJ (July 6, 1995). "Making Sense". <i>The New England Journal of Medicine</i> <b>333</b> (1): 66–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199507063330118">10.1056/NEJM199507063330118</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7777006">7777006</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Making+Sense&amp;rft.au=Hilson+AJ&amp;rft.aulast=Hilson+AJ&amp;rft.date=July+6%2C+1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199507063330118&amp;rft_id=info%3Apmid%2F7777006&amp;rft.issue=1&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=66-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=333" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20200355-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20200355_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Audard V, Zhang SY, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, Baia M, Lang P, Pawlak A, Sahali D. (May 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2890576">"Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes."</a>. <i>Blood.</i> <b>115</b> (18): 3756–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2009-11-251132">10.1182/blood-2009-11-251132</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2890576">2890576</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20200355">20200355</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Occurrence+of+minimal+change+nephrotic+syndrome+in+classical+Hodgkin+lymphoma+is+closely+related+to+the+induction+of+c-mip+in+Hodgkin-Reed+Sternberg+cells+and+podocytes.&amp;rft.au=Audard+V%2C+Zhang+SY%2C+Copie-Bergman+C%2C+Rucker-Martin+C%2C+Ory+V%2C+Candelier+M%2C+Baia+M%2C+Lang+P%2C+Pawlak+A%2C+Sahali+D.&amp;rft.aulast=Audard+V%2C+Zhang+SY%2C+Copie-Bergman+C%2C+Rucker-Martin+C%2C+Ory+V%2C+Candelier+M%2C+Baia+M%2C+Lang+P%2C+Pawlak+A%2C+Sahali+D.&amp;rft.date=May+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2890576&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-11-251132&amp;rft_id=info%3Apmc%2F2890576&amp;rft_id=info%3Apmid%2F20200355&amp;rft.issue=18&amp;rft.jtitle=Blood.&amp;rft.pages=3756-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=115" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21328291-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21328291_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Herbst C, Rehan FA, Skoetz N, Bohlius J, Brillant C, Schulz H, Monsef I, Specht L, Engert A (2011). "Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma". <i>Cochrane Database Syst Rev</i> (2): CD007110. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD007110.pub2">10.1002/14651858.CD007110.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21328291">21328291</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Chemotherapy+alone+versus+chemotherapy+plus+radiotherapy+for+early+stage+Hodgkin+lymphoma&amp;rft.au=Herbst+C%2C+Rehan+FA%2C+Skoetz+N%2C+Bohlius+J%2C+Brillant+C%2C+Schulz+H%2C+Monsef+I%2C+Specht+L%2C+Engert+A&amp;rft.aulast=Herbst+C%2C+Rehan+FA%2C+Skoetz+N%2C+Bohlius+J%2C+Brillant+C%2C+Schulz+H%2C+Monsef+I%2C+Specht+L%2C+Engert+A&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007110.pub2&amp;rft_id=info%3Apmid%2F21328291&amp;rft.issue=2&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD007110&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16172458-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16172458_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M (2005). "ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomised trial by the Intergruppo Italiano Linfomi". <i>J. Clin. Oncol.</i> <b>23</b> (36): 9198–207. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2005.02.907">10.1200/JCO.2005.02.907</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16172458">16172458</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=ABVD+versus+modified+stanford+V+versus+MOPPEBVCAD+with+optional+and+limited+radiotherapy+in+intermediate-+and+advanced-stage+Hodgkin%27s+lymphoma%3A+final+results+of+a+multicenter+randomised+trial+by+the+Intergruppo+Italiano+Linfomi&amp;rft.au=Gobbi+PG%2C+Levis+A%2C+Chisesi+T%2C+Broglia+C%2C+Vitolo+U%2C+Stelitano+C%2C+Pavone+V%2C+Cavanna+L%2C+Santini+G%2C+Merli+F%2C+Liberati+M%2C+Baldini+L%2C+Deliliers+GL%2C+Angelucci+E%2C+Bordonaro+R%2C+Federico+M&amp;rft.aulast=Gobbi+PG%2C+Levis+A%2C+Chisesi+T%2C+Broglia+C%2C+Vitolo+U%2C+Stelitano+C%2C+Pavone+V%2C+Cavanna+L%2C+Santini+G%2C+Merli+F%2C+Liberati+M%2C+Baldini+L%2C+Deliliers+GL%2C+Angelucci+E%2C+Bordonaro+R%2C+Federico+M&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2005.02.907&amp;rft_id=info%3Apmid%2F16172458&amp;rft.issue=36&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=9198-207&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A, Portlock CS, Straus DJ, Zelenetz AD, Yahalom J (March 2010). "Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience". <i>Annals of Oncology</i> <b>21</b> (3): 574–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fannonc%2Fmdp337">10.1093/annonc/mdp337</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19759185">19759185</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Stanford+V+program+for+locally+extensive+and+advanced+Hodgkin+lymphoma%3A+the+Memorial+Sloan-Kettering+Cancer+Center+experience&amp;rft.au=Edwards-Bennett+SM%2C+Jacks+LM%2C+Moskowitz+CH%2C+Wu+EJ%2C+Zhang+Z%2C+Noy+A%2C+Portlock+CS%2C+Straus+DJ%2C+Zelenetz+AD%2C+Yahalom+J&amp;rft.aulast=Edwards-Bennett+SM%2C+Jacks+LM%2C+Moskowitz+CH%2C+Wu+EJ%2C+Zhang+Z%2C+Noy+A%2C+Portlock+CS%2C+Straus+DJ%2C+Zelenetz+AD%2C+Yahalom+J&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdp337&amp;rft_id=info%3Apmid%2F19759185&amp;rft.issue=3&amp;rft.jtitle=Annals+of+Oncology&amp;rft.pages=574-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ghsg.org/en/">"Home | German Hodgkin Study Group"</a>. Ghsg.org<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-08-26</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Home+%26%23124%3B+German+Hodgkin+Study+Group&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fghsg.org%2Fen%2F&amp;rft.pub=Ghsg.org&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Saini KS, Azim HA, Cocorocchio E, Vanazzi A, Saini ML, Raviele PR, Pruneri G, Peccatori FA (2011). "Rituximab in Hodgkin lymphoma: Is the target always a hit?". <i>Cancer Treat Rev</i> <b>37</b> (5): 385–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ctrv.2010.11.005">10.1016/j.ctrv.2010.11.005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21183282">21183282</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Rituximab+in+Hodgkin+lymphoma%3A+Is+the+target+always+a+hit%3F&amp;rft.aulast=Saini+KS%2C+Azim+HA%2C+Cocorocchio+E%2C+Vanazzi+A%2C+Saini+ML%2C+Raviele+PR%2C+Pruneri+G%2C+Peccatori+FA&amp;rft.au=Saini+KS%2C+Azim+HA%2C+Cocorocchio+E%2C+Vanazzi+A%2C+Saini+ML%2C+Raviele+PR%2C+Pruneri+G%2C+Peccatori+FA&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctrv.2010.11.005&amp;rft_id=info%3Apmid%2F21183282&amp;rft.issue=5&amp;rft.jtitle=Cancer+Treat+Rev&amp;rft.pages=385-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Klimm B, Diehl V, Engert A (2007). <a rel="nofollow" class="external text" href="http://www.cancernetwork.com/display/article/10165/59443">"Hodgkin's Lymphoma in the Elderly: A Different Disease in Patients Over 60"</a>. <i>Oncology</i> <b>21</b> (8): 982–90; discussion 990, 996, 998 passim. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17715698">17715698</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Hodgkin%27s+Lymphoma+in+the+Elderly%3A+A+Different+Disease+in+Patients+Over+60&amp;rft.au=Klimm+B%2C+Diehl+V%2C+Engert+A&amp;rft.aulast=Klimm+B%2C+Diehl+V%2C+Engert+A&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancernetwork.com%2Fdisplay%2Farticle%2F10165%2F59443&amp;rft_id=info%3Apmid%2F17715698&amp;rft.issue=8&amp;rft.jtitle=Oncology&amp;rft.pages=982-90%3B+discussion+990%2C+996%2C+998+passim&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.rtanswers.com/treatmentinformation/cancertypes/lymphomas/externalbeam.aspx">"RTanswers.com"</a>. RTanswers.com. 2010-12-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-08-26</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=RTanswers.com&amp;rft.date=2010-12-03&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.rtanswers.com%2Ftreatmentinformation%2Fcancertypes%2Flymphomas%2Fexternalbeam.aspx&amp;rft.pub=RTanswers.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">van Dorp W, van Beek RD, Laven JS, Pieters R, de Muinck Keizer-Schrama SM, van den Heuvel-Eibrink MM (2011). "Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: A review". <i>Human Reproduction Update</i> <b>18</b> (1): 12–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhumupd%2Fdmr038">10.1093/humupd/dmr038</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21896559">21896559</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Long-term+endocrine+side+effects+of+childhood+Hodgkin%27s+lymphoma+treatment%3A+A+review&amp;rft.aulast=van+Dorp+W%2C+van+Beek+RD%2C+Laven+JS%2C+Pieters+R%2C+de+Muinck+Keizer-Schrama+SM%2C+van+den+Heuvel-Eibrink+MM&amp;rft.au=van+Dorp+W%2C+van+Beek+RD%2C+Laven+JS%2C+Pieters+R%2C+de+Muinck+Keizer-Schrama+SM%2C+van+den+Heuvel-Eibrink+MM&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdmr038&amp;rft_id=info%3Apmid%2F21896559&amp;rft.issue=1&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.pages=12-28&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ferm-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ferm_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M (November 2007). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=17989384&amp;promo=ONFLNS19">"Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease"</a>. <i>The New England Journal of Medicine</i> <b>357</b> (19): 1916–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa064601">10.1056/NEJMoa064601</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17989384">17989384</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Chemotherapy+plus+involved-field+radiation+in+early-stage+Hodgkin%27s+disease&amp;rft.au=Ferm%C3%A9+C%2C+Eghbali+H%2C+Meerwaldt+JH%2C+Rieux+C%2C+Bosq+J%2C+Berger+F%2C+Girinsky+T%2C+Brice+P%2C+van%27t+Veer+MB%2C+Walewski+JA%2C+Lederlin+P%2C+Tirelli+U%2C+Carde+P%2C+Van+den+Neste+E%2C+Gyan+E%2C+Monconduit+M%2C+Divin%C3%A9+M%2C+Raemaekers+JM%2C+Salles+G%2C+Noordijk+EM%2C+Creemers+GJ%2C+Gabarre+J%2C+Hagenbeek+A%2C+Reman+O%2C+Blanc+M%2C+Thomas+J%2C+Vi%C3%A9+B%2C+Kluin-Nelemans+JC%2C+Viseu+F%2C+Baars+JW%2C+Poortmans+P%2C+Lugtenburg+PJ%2C+Carrie+C%2C+Jaubert+J%2C+Henry-Amar+M&amp;rft.aulast=Ferm%C3%A9+C%2C+Eghbali+H%2C+Meerwaldt+JH%2C+Rieux+C%2C+Bosq+J%2C+Berger+F%2C+Girinsky+T%2C+Brice+P%2C+van%27t+Veer+MB%2C+Walewski+JA%2C+Lederlin+P%2C+Tirelli+U%2C+Carde+P%2C+Van+den+Neste+E%2C+Gyan+E%2C+Monconduit+M%2C+Divin%C3%A9+M%2C+Raemaekers+JM%2C+Salles+G%2C+Noordijk+EM%2C+Creemers+GJ%2C+Gabarre+J%2C+Hagenbeek+A%2C+Reman+O%2C+Blanc+M%2C+Thomas+J%2C+Vi%C3%A9+B%2C+Kluin-Nelemans+JC%2C+Viseu+F%2C+Baars+JW%2C+Poortmans+P%2C+Lugtenburg+PJ%2C+Carrie+C%2C+Jaubert+J%2C+Henry-Amar+M&amp;rft.date=November+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D17989384%26promo%3DONFLNS19&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa064601&amp;rft_id=info%3Apmid%2F17989384&amp;rft.issue=19&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=1916-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Hasenclever D, Diehl V (November 19, 1998). "A Prognostic Score for Advanced Hodgkin's Disease". <i>New England Journal of Medicine</i> <b>339</b> (21): 1506–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199811193392104">10.1056/NEJM199811193392104</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9819449">9819449</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=A+Prognostic+Score+for+Advanced+Hodgkin%27s+Disease&amp;rft.au=Hasenclever+D%2C+Diehl+V&amp;rft.aulast=Hasenclever+D%2C+Diehl+V&amp;rft.date=November+19%2C+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199811193392104&amp;rft_id=info%3Apmid%2F9819449&amp;rft.issue=21&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=1506-14&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=339" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid23516309-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid23516309_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid23516309_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, Meignan M, Malkowski B, Hofman MS, Barrington SF (2013). "International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers". <i>Journal of Nuclear Medicine</i> <b>54</b> (5): 683–690. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2967%2Fjnumed.112.110890">10.2967/jnumed.112.110890</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23516309">23516309</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=International+Validation+Study+for+Interim+PET+in+ABVD-Treated%2C+Advanced-Stage+Hodgkin+Lymphoma%3A+Interpretation+Criteria+and+Concordance+Rate+Among+Reviewers&amp;rft.au=Biggi+A%2C+Gallamini+A%2C+Chauvie+S%2C+Hutchings+M%2C+Kostakoglu+L%2C+Gregianin+M%2C+Meignan+M%2C+Malkowski+B%2C+Hofman+MS%2C+Barrington+SF&amp;rft.aulast=Biggi+A%2C+Gallamini+A%2C+Chauvie+S%2C+Hutchings+M%2C+Kostakoglu+L%2C+Gregianin+M%2C+Meignan+M%2C+Malkowski+B%2C+Hofman+MS%2C+Barrington+SF&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2967%2Fjnumed.112.110890&amp;rft_id=info%3Apmid%2F23516309&amp;rft.issue=5&amp;rft.jtitle=Journal+of+Nuclear+Medicine&amp;rft.pages=683-690&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html">"WHO Disease and injury country estimates"</a>. <i>World Health Organisation</i>. 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">Nov 11,</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=WHO+Disease+and+injury+country+estimates&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html&amp;rft.jtitle=World+Health+Organisation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation book">Mauch, Peter; James Armitage; Volker Diehl; Richard Hoppe; Laurence Weiss (1999). <i>Hodgkin's Disease</i>. <a href="/wiki/Lippincott_Williams_%26_Wilkins" title="Lippincott Williams &amp; Wilkins">Lippincott Williams &amp; Wilkins</a>. pp.&#160;62–64. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-1502-4" title="Special:BookSources/0-7817-1502-4">0-7817-1502-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.aufirst=Peter&amp;rft.au=James+Armitage&amp;rft.aulast=Mauch&amp;rft.au=Laurence+Weiss&amp;rft.au=Mauch%2C+Peter&amp;rft.au=Richard+Hoppe&amp;rft.au=Volker+Diehl&amp;rft.btitle=Hodgkin%27s+Disease&amp;rft.date=1999&amp;rft.genre=book&amp;rft.isbn=0-7817-1502-4&amp;rft.pages=62-64&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SEER_2014-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-SEER_2014_35-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://seer.cancer.gov/statfacts/html/hodg.html">"SEER Stat Fact Sheets: Leukemia"</a>. <i>NCI Surveillance, Epidemiology, and End Results Program</i><span class="reference-accessdate">. Retrieved <span class="nowrap">18 August</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=SEER+Stat+Fact+Sheets%3A+Leukemia&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fhodg.html&amp;rft.jtitle=NCI+Surveillance%2C+Epidemiology%2C+and+End+Results+Program&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895473">"Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS"</a>. <i>Blood</i> <b>108</b> (12): 3786–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2006-05-024109">10.1182/blood-2006-05-024109</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895473">1895473</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16917006">16917006</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Hodgkin+lymphoma+and+immunodeficiency+in+persons+with+HIV%2FAIDS&amp;rft.au=Biggar+RJ%2C+Jaffe+ES%2C+Goedert+JJ%2C+Chaturvedi+A%2C+Pfeiffer+R%2C+Engels+EA&amp;rft.aulast=Biggar+RJ%2C+Jaffe+ES%2C+Goedert+JJ%2C+Chaturvedi+A%2C+Pfeiffer+R%2C+Engels+EA&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1895473&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2006-05-024109&amp;rft_id=info%3Apmc%2F1895473&amp;rft_id=info%3Apmid%2F16917006&amp;rft.issue=12&amp;rft.jtitle=Blood&amp;rft.pages=3786-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=108" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/hodgkinslymphoma/">"Hodgkin lymphoma statistics"</a>. <i>Cancer Research UK</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Hodgkin+lymphoma+statistics&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fcancer-info%2Fcancerstats%2Ftypes%2Fhodgkinslymphoma%2F&amp;rft.jtitle=Cancer+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10594291-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10594291_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dawson PJ (December 1999). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/00300386">"The original illustrations of Hodgkin's disease"</a>. <i>Annals of Diagnostic Pathology</i> <b>3</b> (6): 386–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:10.1053/ADPA00300386 (inactive 2015-01-01). <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10594291">10594291</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=The+original+illustrations+of+Hodgkin%27s+disease&amp;rft.au=Dawson+PJ&amp;rft.aulast=Dawson+PJ&amp;rft.date=December+1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2F00300386&amp;rft_id=info%3Adoi%2F10.1053%2FADPA00300386&amp;rft_id=info%3Apmid%2F10594291&amp;rft.issue=6&amp;rft.jtitle=Annals+of+Diagnostic+Pathology&amp;rft.pages=386-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Geller1984-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-Geller1984_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Geller1984_39-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Geller1984_39-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Geller1984_39-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Geller1984_39-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Geller SA (August 1984). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2609834">"Comments on the anniversary of the description of Hodgkin's disease"</a>. <i>Journal of the National Medical Association</i> <b>76</b> (8): 815–7. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2609834">2609834</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6381744">6381744</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Comments+on+the+anniversary+of+the+description+of+Hodgkin%27s+disease&amp;rft.au=Geller+SA&amp;rft.aulast=Geller+SA&amp;rft.date=August+1984&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2609834&amp;rft_id=info%3Apmc%2F2609834&amp;rft_id=info%3Apmid%2F6381744&amp;rft.issue=8&amp;rft.jtitle=Journal+of+the+National+Medical+Association&amp;rft.pages=815-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.mariolemieux.org">"Mario Lemieux Foundation"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Mario+Lemieux+Foundation&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.mariolemieux.org&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><span class="citation book">James, TGH (2004). <a rel="nofollow" class="external text" href="http://www.oxforddnb.com/view/article/32312">"Carter, Howard (1874–1939)"</a>. <i>Oxford Dictionary of National Biography</i>. Oxford University Press. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fref%3Aodnb%2F32312">10.1093/ref:odnb/32312</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Carter%2C+Howard+%281874%E2%80%931939%29&amp;rft.aufirst=TGH&amp;rft.au=James%2C+TGH&amp;rft.aulast=James&amp;rft.btitle=Oxford+Dictionary+of+National+Biography&amp;rft.date=2004&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fwww.oxforddnb.com%2Fview%2Farticle%2F32312&amp;rft_id=info%3Adoi%2F10.1093%2Fref%3Aodnb%2F32312&amp;rft.pub=Oxford+University+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.msnbc.msn.com/id/14371567/">"Teen, court reach agreement over cancer care"</a>. MSNBC. Associated Press. September 5, 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Teen%2C+court+reach+agreement+over+cancer+care&amp;rft.date=September+5%2C+2006&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.msnbc.msn.com%2Fid%2F14371567%2F&amp;rft.pub=MSNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.nytimes.com/2009/05/16/us/16brfs-EVALUATIONOR_BRF.html?_r=1&amp;scp=4&amp;sq=daniel%20hauser&amp;st=cse">"Minnesota: Evaluation Ordered for a 13-Year-Old With Cancer"</a>. NY Times. Associated Press. May 16, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Minnesota%3A+Evaluation+Ordered+for+a+13-Year-Old+With+Cancer&amp;rft.date=May+16%2C+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2009%2F05%2F16%2Fus%2F16brfs-EVALUATIONOR_BRF.html%3F_r%3D1%26scp%3D4%26sq%3Ddaniel%2520hauser%26st%3Dcse&amp;rft.pub=NY+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.dailymail.co.uk/health/article-459909/Doctors-said-I-needed-rest--fact-cancer-slowly-killing-says-Delta-Goodrem.html">"Doctors said all I needed was rest - in fact cancer was slowly killing me, says Delta Goodrem | Daily Mail Online"</a>. Dailymail.co.uk. 2007-06-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-03-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Doctors+said+all+I+needed+was+rest+-+in+fact+cancer+was+slowly+killing+me%2C+says+Delta+Goodrem+%26%23124%3B+Daily+Mail+Online&amp;rft.date=2007-06-05&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Farticle-459909%2FDoctors-said-I-needed-rest--fact-cancer-slowly-killing-says-Delta-Goodrem.html&amp;rft.pub=Dailymail.co.uk&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.ariacharts.com.au/news/41038/celebrating-30-years-of-the-aria-charts?pos=0">"CELEBRATING 30 YEARS OF THE ARIA CHARTS - ARIA Music News"</a>. Ariacharts.com.au. 1983-07-10<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-03-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=CELEBRATING+30+YEARS+OF+THE+ARIA+CHARTS+-+ARIA+Music+News&amp;rft.date=1983-07-10&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.ariacharts.com.au%2Fnews%2F41038%2Fcelebrating-30-years-of-the-aria-charts%3Fpos%3D0&amp;rft.pub=Ariacharts.com.au&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.people.com/people/article/0,,20138440,00.html">"Lionhearted - Death, Richard Harris"</a>. People.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-03-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.btitle=Lionhearted+-+Death%2C+Richard+Harris&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.people.com%2Fpeople%2Farticle%2F0%2C%2C20138440%2C00.html&amp;rft.pub=People.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text">Wikipedia</span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://espn.go.com/nfl/story/_/id/12000374/eric-berry-kansas-city-chiefs-diagnosed-hodgkin-lymphoma">"Eric Berry has Hodgkin's lymphoma"</a>. <i>ESPN.com</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.atitle=Eric+Berry+has+Hodgkin%27s+lymphoma&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fespn.go.com%2Fnfl%2Fstory%2F_%2Fid%2F12000374%2Feric-berry-kansas-city-chiefs-diagnosed-hodgkin-lymphoma&amp;rft.jtitle=ESPN.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation web">Huver, Scott (2010-07-23). <a rel="nofollow" class="external text" href="http://www.people.com/people/article/0,,20404733,00.html">"Cancer-Free Michael C. Hall Back to Work on Dexter - Health, Dexter, Michael C. Hall"</a>. People.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-03-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHodgkin%27s+lymphoma&amp;rft.aufirst=Scott&amp;rft.au=Huver%2C+Scott&amp;rft.aulast=Huver&amp;rft.btitle=Cancer-Free+Michael+C.+Hall+Back+to+Work+on+Dexter+-+Health%2C+Dexter%2C+Michael+C.+Hall&amp;rft.date=2010-07-23&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.people.com%2Fpeople%2Farticle%2F0%2C%2C20404733%2C00.html&amp;rft.pub=People.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="Further_reading">Further reading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=16" title="Edit section: Further reading">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li>Charlotte DeCroes Jacobs. <i>Henry Kaplan and the Story of Hodgkin's Disease</i> (<a href="/wiki/Stanford_University_Press" title="Stanford University Press">Stanford University Press</a>; 2010) 456 pages; combines a biography of the American radiation oncologist (1918–84) with a history of the lymphatic cancer whose treatment he helped to transform.</li>
</ul>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit&amp;section=17" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="mbox-small plainlinks sistersitebox" style="border:1px solid #aaa;background-color:#f9f9f9">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="//commons.wikimedia.org/wiki/Category:Hodgkin%27s_lymphoma" class="extiw" title="commons:Category:Hodgkin's lymphoma">Hodgkin's lymphoma</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=84">Hodgkin Disease</a> at <a href="/wiki/American_Cancer_Society" title="American Cancer Society">American Cancer Society</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/hodgkinslymphoma">Hodgkin's Lymphoma</a> at the American <a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">National Cancer Institute</a></li>
<li>Clinically reviewed <a rel="nofollow" class="external text" href="http://www.cancerhelp.org.uk/type/hodgkins-lymphoma/">Hodgkin's lymphoma information</a> for patients, from <a href="/wiki/Cancer_Research_UK" title="Cancer Research UK">Cancer Research UK</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymphoid_malignancy" title="Template talk:Lymphoid malignancy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymphoid_malignancy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology#.289590.E2.80.939999.29_Hematologic_.28Leukemias.2C_Lymphomas_and_related_disorders.29" title="International Classification of Diseases for Oncology">ICD-O 9590–9989</a>, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81.E2.80.93C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81–C96</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200.E2.80.93208.29" title="List of ICD-9 codes 140–239: neoplasms">200–208</a>)<br />
<a href="/wiki/Lymphocyte" title="Lymphocyte">Lymphoid</a>/<a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative</a>, <a href="/wiki/Lymphoma" title="Lymphoma">Lymphomas</a>/<a href="/wiki/Lymphoid_leukemia" title="Lymphoid leukemia">Lymphoid leukemias</a> (9590–9739, 9800–9839)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_B_cell_neoplasms" title="Lymphoma">B cell</a><br />
(<a href="/wiki/B-cell_lymphoma" title="B-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/B-cell_leukemia" title="B-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD19" title="CD19">CD19</a>
<ul>
<li><a href="/wiki/CD20" title="CD20">CD20</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_B-cell_lymphoblastic_leukemia" title="Precursor B-cell lymphoblastic leukemia">Precursor B acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Naive_B_cell" title="Naive B cell">naive B cell</a></i> (<a href="/wiki/B-cell_chronic_lymphocytic_leukemia" title="B-cell chronic lymphocytic leukemia">CLL/SLL</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Mantle_zone" title="Mantle zone">mantle zone</a></i> (<a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD22" title="CD22">CD22</a>+</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/B-cell_prolymphocytic_leukemia" title="B-cell prolymphocytic leukemia">Prolymphocytic</a></li>
<li><i><a href="/wiki/CD11c" title="CD11c">CD11c+</a></i> (<a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD79A" title="CD79A">CD79a</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Germinal_center" title="Germinal center">germinal center</a>/<a href="/wiki/Follicular_B_cell" title="Follicular B cell">follicular B cell</a></i> (<a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular</a></li>
<li><a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's</a></li>
<li><a href="/wiki/GCB_DLBCL" title="GCB DLBCL" class="mw-redirect">GCB DLBCL</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Marginal_zone_B-cell_lymphoma" title="Marginal zone B-cell lymphoma">marginal zone</a>/<a href="/wiki/Marginal-zone_B_cell" title="Marginal-zone B cell" class="mw-redirect">marginal-zone B cell</a></i> (<a href="/wiki/Splenic_marginal_zone_lymphoma" title="Splenic marginal zone lymphoma">Splenic marginal zone</a></li>
<li><a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT</a></li>
<li><a href="/wiki/Nodal_marginal_zone_B_cell_lymphoma" title="Nodal marginal zone B cell lymphoma">Nodal marginal zone</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reed-Sternberg_cell" title="Reed-Sternberg cell" class="mw-redirect">RS</a> (<a href="/wiki/CD15" title="CD15">CD15</a>+, <a href="/wiki/CD30" title="CD30">CD30</a>+)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Classic Hodgkin's lymphoma</strong> (<a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">Nodular sclerosis</a>)</li>
<li><i><a href="/wiki/CD20" title="CD20">CD20+</a></i> (<a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">Nodular lymphocyte predominant Hodgkin's lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Plasma_cell_dyscrasia" title="Plasma cell dyscrasia">PCDs</a>/<a href="/wiki/Paraproteinemia" title="Paraproteinemia">PP</a><br />
(<a href="/wiki/CD38" title="CD38">CD38</a>+/<a href="/wiki/CD138" title="CD138" class="mw-redirect">CD138</a>+)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>see <a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">immunoproliferative immunoglobulin disorders</a></i></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Kaposi%27s_sarcoma-associated_herpesvirus" title="Kaposi's sarcoma-associated herpesvirus">KSHV</a></i> (<a href="/wiki/Primary_effusion_lymphoma" title="Primary effusion lymphoma">Primary effusion</a>)</li>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Lymphomatoid_granulomatosis" title="Lymphomatoid granulomatosis">Lymphomatoid granulomatosis</a></li>
<li><a href="/wiki/Post-transplant_lymphoproliferative_disorder" title="Post-transplant lymphoproliferative disorder">Post-transplant lymphoproliferative disorder</a>)</li>
<li><i><a href="/wiki/HIV" title="HIV">HIV</a></i> (<a href="/wiki/AIDS-related_lymphoma" title="AIDS-related lymphoma">AIDS-related lymphoma</a>)</li>
<li><i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i> (<a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_B-cell_lymphoma" title="Cutaneous B-cell lymphoma">Cutaneous</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diffuse_large_B-cell_lymphoma" title="Diffuse large B-cell lymphoma">Diffuse large B-cell lymphoma</a></li>
<li><a href="/wiki/Intravascular_large_B-cell_lymphoma" title="Intravascular large B-cell lymphoma">Intravascular large B-cell lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_immunocytoma" title="Primary cutaneous immunocytoma">Primary cutaneous immunocytoma</a></li>
<li><a href="/wiki/Plasmacytoma" title="Plasmacytoma">Plasmacytoma</a></li>
<li><a href="/wiki/Plasmacytosis" title="Plasmacytosis">Plasmacytosis</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">T/NK</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/T_cell" title="T cell">T cell</a><br />
(<a href="/wiki/T-cell_lymphoma" title="T-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/T-cell_leukemia" title="T-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a>
<ul>
<li><a href="/wiki/CD4" title="CD4">CD4</a></li>
<li><a href="/wiki/CD8" title="CD8">CD8</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a>: <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_T-cell_lymphoblastic_leukemia" title="Precursor T-cell lymphoblastic leukemia" class="mw-redirect">Precursor T acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Prolymphocyte" title="Prolymphocyte">prolymphocyte</a></i> (<a href="/wiki/T-cell_prolymphocytic_leukemia" title="T-cell prolymphocytic leukemia">Prolymphocytic</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/CD30" title="CD30">CD30+</a></i> (<a href="/wiki/Anaplastic_large-cell_lymphoma" title="Anaplastic large-cell lymphoma">Anaplastic large-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_T-cell_lymphoma" title="Cutaneous T-cell lymphoma" class="mw-redirect">Cutaneous</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">MF+variants</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>indolent:</i> <a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">Mycosis fungoides</a></li>
<li><a href="/wiki/Pagetoid_reticulosis" title="Pagetoid reticulosis">Pagetoid reticulosis</a></li>
<li><a href="/wiki/Granulomatous_slack_skin" title="Granulomatous slack skin">Granulomatous slack skin</a></li>
</ul>
<p><i>aggressive:</i> <a href="/wiki/S%C3%A9zary_disease" title="Sézary disease">Sézary disease</a></p>
<ul>
<li><a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Non-MF</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>-: <a href="/wiki/Non-mycosis_fungoides_CD30%E2%88%92_cutaneous_large_T-cell_lymphoma" title="Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma">Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma</a></li>
<li><a href="/wiki/Pleomorphic_T-cell_lymphoma" title="Pleomorphic T-cell lymphoma">Pleomorphic T-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type B</a></li>
</ul>
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>+: <a href="/wiki/CD30%2B_cutaneous_T-cell_lymphoma" title="CD30+ cutaneous T-cell lymphoma">CD30+ cutaneous T-cell lymphoma</a></li>
<li><a href="/wiki/Secondary_cutaneous_CD30%2B_large_cell_lymphoma" title="Secondary cutaneous CD30+ large cell lymphoma" class="mw-redirect">Secondary cutaneous CD30+ large cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other <a href="/wiki/Peripheral_T-cell_lymphoma" title="Peripheral T-cell lymphoma">peripheral</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hepatosplenic_T-cell_lymphoma" title="Hepatosplenic T-cell lymphoma">Hepatosplenic</a></li>
<li><a href="/wiki/Angioimmunoblastic_T-cell_lymphoma" title="Angioimmunoblastic T-cell lymphoma">Angioimmunoblastic</a></li>
<li><a href="/wiki/Enteropathy-associated_T-cell_lymphoma" title="Enteropathy-associated T-cell lymphoma">Enteropathy-associated T-cell lymphoma</a></li>
<li><a href="/wiki/Peripheral_T-cell_lymphoma-Not-Otherwise-Specified" title="Peripheral T-cell lymphoma-Not-Otherwise-Specified" class="mw-redirect">Peripheral T-cell lymphoma-Not-Otherwise-Specified</a> (<a href="/wiki/Lennert_lymphoma" title="Lennert lymphoma">Lennert lymphoma</a>)</li>
<li><a href="/wiki/Subcutaneous_T-cell_lymphoma" title="Subcutaneous T-cell lymphoma">Subcutaneous T-cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Human_T-lymphotropic_virus_1" title="Human T-lymphotropic virus 1">HTLV-1</a></i> (<a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">NK cell</a>/<br />
(most <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aggressive_NK-cell_leukemia" title="Aggressive NK-cell leukemia">Aggressive NK-cell leukemia</a></li>
<li><a href="/wiki/Blastic_NK_cell_lymphoma" title="Blastic NK cell lymphoma">Blastic NK cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">T or NK</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Extranodal_NK-T-cell_lymphoma" title="Extranodal NK-T-cell lymphoma" class="mw-redirect">Extranodal NK-T-cell lymphoma</a>/<a href="/wiki/Angiocentric_lymphoma" title="Angiocentric lymphoma" class="mw-redirect">Angiocentric lymphoma</a>)</li>
<li><a href="/wiki/Large_granular_lymphocytic_leukemia" title="Large granular lymphocytic leukemia">Large granular lymphocytic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Lymphoid+myeloid</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphocytosis" title="Lymphocytosis">Lymphocytosis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative disorders</a> (<a href="/wiki/X-linked_lymphoproliferative_disease" title="X-linked lymphoproliferative disease">X-linked lymphoproliferative disease</a></li>
<li><a href="/wiki/Autoimmune_lymphoproliferative_syndrome" title="Autoimmune lymphoproliferative syndrome">Autoimmune lymphoproliferative syndrome</a>)</li>
<li><a href="/wiki/Leukemoid_reaction" title="Leukemoid reaction">Leukemoid reaction</a></li>
<li><a href="/wiki/Diffuse_infiltrative_lymphocytosis_syndrome" title="Diffuse infiltrative lymphocytosis syndrome">Diffuse infiltrative lymphocytosis syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a>
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_bandlike_and_perivascular_patterns" title="Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns" class="mw-redirect">with bandlike and perivascular patterns</a></li>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_nodular_pattern" title="Cutaneous lymphoid hyperplasia with nodular pattern" class="mw-redirect">with nodular pattern</a></li>
</ul>
</li>
<li><a href="/wiki/Jessner_lymphocytic_infiltrate_of_the_skin" title="Jessner lymphocytic infiltrate of the skin" class="mw-redirect">Jessner lymphocytic infiltrate of the skin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymph_immune_and_complement_navs" title="Template:Lymph immune and complement navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymph_immune_and_complement_navs" title="Template talk:Lymph immune and complement navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymph_immune_and_complement_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Immune_system" title="Immune system">immune system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">Physiology</a>
<ul>
<li><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cells</a></li>
<li><a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">autoantigens</a></li>
<li><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">autoantibodies</a></li>
<li><a href="/wiki/Template:Complement_system" title="Template:Complement system">complement</a></li>
<li><a href="/wiki/Template:Surface_antigens" title="Template:Surface antigens">surface antigens</a></li>
<li><a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">IG receptors</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Allergic_conditions" title="Template:Allergic conditions">Allergies</a></li>
<li><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">Immunodeficiency</a></li>
<li><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">Immunoproliferative immunoglobulin disorders</a></li>
<li><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">Hypersensitivity and autoimmune disorders</a></li>
<li><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">Neoplasms and cancer</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antihistamines" title="Template:Antihistamines">antihistamines</a></li>
<li><a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">immunostimulants</a></li>
<li><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">immunosuppressants</a></li>
<li><a href="/wiki/Template:Monoclonals_for_immune_system" title="Template:Monoclonals for immune system">monoclonal antibodies</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1248
CPU time usage: 0.600 seconds
Real time usage: 0.736 seconds
Preprocessor visited node count: 4679/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 229259/2097152 bytes
Template argument size: 3781/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 4/500
Lua time usage: 0.197/10.000 seconds
Lua memory usage: 4.18 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  580.118      1 - -total
 38.50%  223.362      1 - Template:Reflist
 17.20%   99.776      8 - Template:Navbox
 12.98%   75.275      1 - Template:Infobox_disease
 11.57%   67.137     25 - Template:Cite_journal
 11.39%   66.077      1 - Template:Infobox
 10.19%   59.124      4 - Template:Citation_needed
  9.13%   52.983      1 - Template:Hematological_malignancy_histology
  8.31%   48.229      4 - Template:Fix
  7.43%   43.104      8 - Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:23713759-0!*!0!!en!4!* and timestamp 20150710230722 and revision id 669324052
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Hodgkin%27s_lymphoma&amp;oldid=669324052">https://en.wikipedia.org/w/index.php?title=Hodgkin%27s_lymphoma&amp;oldid=669324052</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Rare_cancers" title="Category:Rare cancers">Rare cancers</a></li><li><a href="/wiki/Category:Hodgkin%27s_lymphoma" title="Category:Hodgkin's lymphoma">Hodgkin's lymphoma</a></li><li><a href="/wiki/Category:Infectious_causes_of_cancer" title="Category:Infectious causes of cancer">Infectious causes of cancer</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Pages_with_DOIs_inactive_since_2015" title="Category:Pages with DOIs inactive since 2015">Pages with DOIs inactive since 2015</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2008" title="Category:Articles with unsourced statements from October 2008">Articles with unsourced statements from October 2008</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_January_2009" title="Category:Articles needing additional references from January 2009">Articles needing additional references from January 2009</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_August_2014" title="Category:Articles with unsourced statements from August 2014">Articles with unsourced statements from August 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_September_2013" title="Category:Articles with unsourced statements from September 2013">Articles with unsourced statements from September 2013</a></li><li><a href="/wiki/Category:Commons_category_with_local_link_same_as_on_Wikidata" title="Category:Commons category with local link same as on Wikidata">Commons category with local link same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hodgkin%27s+lymphoma&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hodgkin%27s+lymphoma" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Hodgkin%27s_lymphoma"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Hodgkin%27s_lymphoma"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Hodgkin%27s_lymphoma" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Hodgkin%27s_lymphoma" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Hodgkin%27s_lymphoma" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;oldid=669324052" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q209369" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Hodgkin%27s_lymphoma&amp;id=669324052" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Hodgkin%27s+lymphoma">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Hodgkin%27s+lymphoma&amp;oldid=669324052&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Hodgkin%27s_lymphoma&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%84%D9%85%D9%81%D9%88%D9%85%D8%A9_%D9%87%D9%88%D8%AF%D8%AC%D9%83%D9%8A%D9%86" title="لمفومة هودجكين – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Malaltia_de_Hodgkin" title="Malaltia de Hodgkin – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Hodgkin%C5%AFv_lymfom" title="Hodgkinův lymfom – Czech" lang="cs" hreflang="cs">Čeština</a></li><li class="interlanguage-link interwiki-de badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//de.wikipedia.org/wiki/Hodgkin-Lymphom" title="Hodgkin-Lymphom – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-dv"><a href="//dv.wikipedia.org/wiki/%DE%8D%DE%A8%DE%89%DE%B0%DE%8A%DE%AF%DE%89%DE%A7_(_%DE%80%DE%AE%DE%96%DE%B0%DE%86%DE%A8%DE%82%DE%B0%DE%90%DE%B0)" title="ލިމްފޯމާ ( ހޮޖްކިންސް) – Divehi" lang="dv" hreflang="dv">ދިވެހިބަސް</a></li><li class="interlanguage-link interwiki-et"><a href="//et.wikipedia.org/wiki/Hodgkini_l%C3%BCmfoom" title="Hodgkini lümfoom – Estonian" lang="et" hreflang="et">Eesti</a></li><li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%9B%CE%AD%CE%BC%CF%86%CF%89%CE%BC%CE%B1_Hodgkin" title="Λέμφωμα Hodgkin – Greek" lang="el" hreflang="el">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Enfermedad_de_Hodgkin" title="Enfermedad de Hodgkin – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Hodgkinen_linfoma" title="Hodgkinen linfoma – Basque" lang="eu" hreflang="eu">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%84%D9%86%D9%81%D9%88%D9%85_%D9%87%D9%88%DA%86%DA%A9%DB%8C%D9%86" title="لنفوم هوچکین – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Lymphome_de_Hodgkin" title="Lymphome de Hodgkin – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Galar_Hodgkin" title="Galar Hodgkin – Irish" lang="ga" hreflang="ga">Gaeilge</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Limfoma_Hodgkin" title="Limfoma Hodgkin – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Linfoma_di_Hodgkin" title="Linfoma di Hodgkin – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9C%D7%99%D7%9E%D7%A4%D7%95%D7%9E%D7%AA_%D7%94%D7%95%D7%93%D7%92%27%D7%A7%D7%99%D7%9F" title="לימפומת הודג'קין – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-ka"><a href="//ka.wikipedia.org/wiki/%E1%83%AE%E1%83%9D%E1%83%AF%E1%83%99%E1%83%98%E1%83%9C%E1%83%98%E1%83%A1_%E1%83%9A%E1%83%98%E1%83%9B%E1%83%A4%E1%83%9D%E1%83%9B%E1%83%90" title="ხოჯკინის ლიმფომა – Georgian" lang="ka" hreflang="ka">ქართული</a></li><li class="interlanguage-link interwiki-la"><a href="//la.wikipedia.org/wiki/Morbus_Hodgkin" title="Morbus Hodgkin – Latin" lang="la" hreflang="la">Latina</a></li><li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/Hod%C5%BEkina_limfoma" title="Hodžkina limfoma – Latvian" lang="lv" hreflang="lv">Latviešu</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Hod%C5%BEkino_limfoma" title="Hodžkino limfoma – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Hodgkin-k%C3%B3r" title="Hodgkin-kór – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Limfoma_Hodgkin" title="Limfoma Hodgkin – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Ziekte_van_Hodgkin" title="Ziekte van Hodgkin – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%9B%E3%82%B8%E3%82%AD%E3%83%B3%E3%83%AA%E3%83%B3%E3%83%91%E8%85%AB" title="ホジキンリンパ腫 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Hodgkins_lymfom" title="Hodgkins lymfom – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Ziarnica_z%C5%82o%C5%9Bliwa" title="Ziarnica złośliwa – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Linfoma_de_Hodgkin" title="Linfoma de Hodgkin – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Limfom_Hodgkin" title="Limfom Hodgkin – Romanian" lang="ro" hreflang="ro">Română</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9B%D0%B8%D0%BC%D1%84%D0%BE%D0%B3%D1%80%D0%B0%D0%BD%D1%83%D0%BB%D0%B5%D0%BC%D0%B0%D1%82%D0%BE%D0%B7" title="Лимфогранулематоз – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%A5%D0%BE%D1%9F%D0%BA%D0%B8%D0%BD%D0%BE%D0%B2%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82" title="Хоџкинова болест – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Hod%C5%BEkinova_bolest" title="Hodžkinova bolest – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Hodgkinin_tauti" title="Hodgkinin tauti – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Hodgkins_lymfom" title="Hodgkins lymfom – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-tl"><a href="//tl.wikipedia.org/wiki/Lymphoma_ni_Hodgkin" title="Lymphoma ni Hodgkin – Tagalog" lang="tl" hreflang="tl">Tagalog</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B8%95%E0%B9%88%E0%B8%AD%E0%B8%A1%E0%B8%99%E0%B9%89%E0%B8%B3%E0%B9%80%E0%B8%AB%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%87%E0%B8%8A%E0%B8%99%E0%B8%B4%E0%B8%94%E0%B8%AE%E0%B8%AD%E0%B8%94%E0%B8%88%E0%B9%8C%E0%B8%81%E0%B8%B4%E0%B8%99" title="มะเร็งต่อมน้ำเหลืองชนิดฮอดจ์กิน – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Hodgkin_lenfoma" title="Hodgkin lenfoma – Turkish" lang="tr" hreflang="tr">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%9B%D1%96%D0%BC%D1%84%D0%BE%D0%B3%D1%80%D0%B0%D0%BD%D1%83%D0%BB%D0%B5%D0%BC%D0%B0%D1%82%D0%BE%D0%B7" title="Лімфогранулематоз – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-ur"><a href="//ur.wikipedia.org/wiki/%DB%81%D8%A7%D8%AC%DA%A9%D9%86_%D8%B3%DB%8C%D8%A7%D9%84%D9%88%D9%85%DB%81" title="ہاجکن سیالومہ – Urdu" lang="ur" hreflang="ur">اردو</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%9C%8D%E5%A5%87%E9%87%91%E6%B7%8B%E5%B7%B4%E7%98%A4" title="霍奇金淋巴瘤 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q209369#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 30 June 2015, at 12:21.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Hodgkin%27s_lymphoma&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":122,"wgHostname":"mw1028"});
}</script>
	</body>
</html>
